background to prehabilitation in wales · jun 2011. jul 2011. aug 2011. sep 2011. oct 2011. days....

Background to Prehabilitation in Wales

Dr Rachael Barlow, Lead Prehabilitation and Enhanced RecoveryCardiff and Vale UHB and Swansea Bay UHB,

Cardiff and University

‘’Nutrition – the Skeleton in the Hospital Cupboard’’

Malnourished patients are two to three times more likely to develop a surgical site infection

or postoperative pneumonia(Arch Surg 2010;145:148-151)

'The Health Foundation Is building a cadre of skilled, motivated professionals who have the right leadership potential and a dedication to improve the quality of service delivered to NHS patients.'

Sir Ian Caruthers OBE Chief Executive of the South West Strategic Health Authority

Leading Practice through Research Fellowship, 2003

‘knowing about research is not the same as using it’

How do you change Practice?

Locally, regionally..... For all patients in Wales

WHAT MAKES CHANGE HAPPEN?

So many processes and interventions.......And people.....

Health care is complex......

................Variation in practices inevitable

All Wales ERAS Collaborative

Improving surgical outcome

Pre-habilitation

Peri-operative/Intra-operative Post-operative

Pre-operative

ClinicPrimary Care DOSA

and WardTheatre/Recovery

Ward and Discharge

Basic Principles of ERAS:

• Best possible condition for surgery• Best possible management during and after

his/her operation• Experiences the best possible rehabilitation,

returning them to their normal activities quicker.

Invest to Save Scheme Welsh Government

£1 Million

Length of Hospital Stay – All Wales

0

2

4

6

8

10

12

Aug2010

Sep2010

Oct2010

Nov2010

Dec2010

Jan2011

Feb2011

Mar2011

Apr2011

May2011

Jun2011

Jul2011

Aug2011

Sep2011

Oct2011

Day

s

Months

In hospital from Aug 2010 to Oct 2011

LHB2+4

LHB1

LHB3

LHB 6 collecting data but poor quality and inconsistent

All sites active

LHB 5

FIRST STEP OF ALL WALES ENHANCED RECOVERY:PREHAB AND PRIMARY CARE OPTIMISATION????

Directors of Primary Care wanted research to demonstrate feasibility of Primary Care and Prehabilitation (discussed in 2010!)

Prehabilitation and Pre Cancer Optimisation –plus hidden benefits for Public Health

Summary Results

• Pre treatment optimisation in primary care is feasible

• Primary Care staff including GPs like the concept and will use it

• 44% of the patients recruited needed someform of intervention and optimisation at the initial stage in primary care

Feedback from Primary Care1. What did you like about the concepts behind Fit for List research

study? “Very sensible. So often they (patients) get to a pre opassessment and stall due to poor BP etc. and then are referredback to us! OR are a higher anaesthetic risk than they need beOR they recovery is not optimised.” (Helen Jones, Barry)

2. Do you think it benefits your patients and why if so?“Yes I believe so -Patients benefit as we can give them advice reoptimising their health whether or not urgent surgery needed. Oftenthey are very receptive at this vulnerable time.” (Helen Jones, Barry)

3. “This is something that should be routinely done for all patients.” (Dr Crouch, Barry)

Cancellations in Wales

84,477 procedures cancelled

11.2 % Medical Reasons

* 1 health board had 1,464 occasions operations had to be cancelled due to a lack of ward beds over last 2.5 years = 1.6 patients every day.

Length of hospital stay in Wales

• Longer than Scotland and England generally• Pockets of good practice but not widespread

and system wide

Reasons:1. Poor fitness prior to surgery2. Poor general health status3. System needs to change

Impact of Deprivation on Length of Stay

Deprivation increases LOS by 1.5 day for Colectomy

(20% least deprived v.s 60-80% most deprived)

• Less ‘fit’ patients are more likely to die

• Less ‘fit’ patients have a more complicated

recovery

• Fitness affects outcomes of cancer patients

• ‘Teachable moment’ - opportunity to embed

sustained changes in health behaviour

What we Know

Can prehabilitation make surgery a viable option for a newly diagnosed patient with cancer who is initially

deemed to be toohigh of a risk for surgical resection?

Gemma Thomas, Ira Goldsmith and colleagues Thoracic Surgery

Pre-treatment Optimisation and Prehabilitation programme

Tour De France

Background to POP Programme

• Funded awarded via the Cancer Implementation Group, Welsh Government April 15

• Circa £380K over 3 years• National and Local Task and Finish Groups

Lung Cancer Prehab Programme CAV only Outcomes

Chart1

6MWT6MWT6MWT

WeightWeightWeight

Fat free massFat free massFat free mass

Hand gripHand gripHand grip

FACIT-fFACIT-fFACIT-f

EQ5D-5LEQ5D-5LEQ5D-5L

Increased (%)

Remained the same (%)

Decreased (%)

%

Percentage Change in Outcomes

84

0

16

61

3

36

80

0

20

33

50

17

50

4

46

48

26

26

therapy data

Laboratory TestsWhich therapists did the patient see?Dietetic OutcomesPhysiotherapy OutcomesOccupational Therapy Outcomes

FBCWhite Blood Cell CountHbU + E'sCreatinineLFT'sHbA1cCRPFinal StagingMDTl StagingPathological StagingPhysiotherapistDietitianOccupational TherapistWeightHeight% Weight LossBody Mass Index% Body FatMUST ScoreMid Upper Arm CircumferenceMid Upper Muscle CircumferenceHand Grip StrengthLean Body Mass (hyperlink)Waist to Hip Ratio6 Minute Walk TestLevel of DesaturationMRC (1-5)FEV1/FVC (actual values)FEF 25% - 75%Blood PressureHeart Rate (bpm)OT AssessmentPre-TreatmentPost-Treatment

Patient CodeDOB (dd/mm/yy)Health BoardAgeSexDate Requested (dd/mm/yy)Are these results normal?Date Requested (dd/mm/yy)Are these results normal?Date Requested (dd/mm/yy)Are these results normal?ResultsDate Requested (dd/mm/yy)Are these results normal?Date Requested (dd/mm/yy)Are these results normal?Date Requested (dd/mm/yy)Are these results normal?Date Requested (dd/mm/yy)Are these results normal?Date Requested (dd/mm/yy)Are these results normal?Diagnosis of Lung Cancer made?If no, what info was given to the patient or what service signposted to?If selected 'other', give details belowPrimary or Secondary CancerIf a diagnosis of lung cancer is made please note the type belowTNMTRTLNRNLMRMLPtNDate planned for Surgery (if applicable, dd/mm/yy)Date planned for Chemotherapy (if applicable, dd/mm/yy)Date planned for Radiotherapy (if applicable, dd/mm/yy)Did the patient attend prehabilitation?Date of first contact (dd/mm/yy)No of Telephone CallsNo of Home VisitsNo of Clinic AppointmentsTotal number of ContactsTotal number of minutes spent with patient (excluding admin)Date of first contact (dd/mm/yy)No of Telephone CallsNo of Home VisitsNo of Clinic AppointmentsTotal number of ContactsTotal number of minutes spent with patient (excluding admin)Date of first contact (dd/mm/yy)No of Telephone CallsNo of Home VisitsNo of Clinic AppointmentsTotal number of ContactsTotal number of minutes spent with patient (excluding admin)Total amount of admin time spent on patient (minutes)Other Health Professional AccessedOther Health Professional AccessedDate (dd/mm/yy)Dietetic Assessment (weight in kg)Pre-Treatment 1 (weight in kg)WT Overall ChangeDate (dd/mm/yy)Baseline Height (metres)Percentage weight loss in last 6 monthsDate (dd/mm/yy)(% wt loss) Dietetic AssessmentDate (dd/mm/yy)(% weight loss) Pre-Treatment 1 (weight in kg)Date (dd/mm/yy)Pre-Treatment 2Date (dd/mm/yy)Post-Treatment% WT loss Overall ChangeDate (dd/mm/yy)(BMI) Dietetic AssessmentDate (dd/mm/yy)(BMI) Pre-Treatment 1Date (dd/mm/yy)Pre-Treatment 2Date (dd/mm/yy)Post-TreatmentBMI Overall ChangeDate (dd/mm/yy)(%body fat) Dietetic AssessmentDate (dd/mm/yy)(%body fat) Pre-Treatment 1Date (dd/mm/yy)(%body fat) Pre-Treatment 2Date (dd/mm/yy)Post-Treatment% Body Fat Overall ChangeDate (dd/mm/yy)(MUST) Dietetic AssessmentDate (dd/mm/yy)(MUST) Pre-Treatment 1Date (dd/mm/yy)(MUST) Pre-Treatment 2Date (dd/mm/yy)Post-TreatmentMUST Overall ChangeDate (dd/mm/yy)(MUAC) Dietetic Assessment (cm)Date (dd/mm/yy)(MUAC) Pre-Treatment 1 (cm)Date (dd/mm/yy)(MUAC) Pre-Treatment 2 (cm)Date (dd/mm/yy)Post-Treatment (cm)MUAC Overall ChangeDate (dd/mm/yy)(MUMC) Dietetic Assessment (cm)Date (dd/mm/yy)(MUMC) Pre-Treatment 1 (cm)Date (dd/mm/yy)(MUMC) Pre-Treatment 2 (cm)Date (dd/mm/yy)(MUMC) Post-Treatment (cm)MUMC Overall ChangeDate (dd/mm/yy)(HG) Dietetic Assessment (mmHg)Date (dd/mm/yy)(HG) Pre-Treatment 1 (mmHg)Date (dd/mm/yy)(HG) Pre-Treatment 2 (mmHg)Date (dd/mm/yy)(HG) Post-Treatment (mmHg)HG Overall ChangeDate (dd/mm/yy)(LEAN BM) Dietetic AssessmentDate (dd/mm/yy)(LEAN BM) Pre-Treatment 1Date (dd/mm/yy)(LEAN BM) Pre-Treatment 2Date (dd/mm/yy)(LEAN BM) Post-TreatmentLean BM Overall ChangeDate (dd/mm/yy)Dietetic AssessmentDate (dd/mm/yy)Pre-Treatment 1Date (dd/mm/yy)Pre-Treatment 2Date (dd/mm/yy)Post-TreatmentOverall ChangeDate (dd/mm/yy)6MWT Physio Assessment (metres)Date (dd/mm/yy)6MWT Pre-Treatment 1 (metres)Date (dd/mm/yy)Pre-Treatment 2 (metres)Date (dd/mm/yy)Post-Treatment (metres)6MWT Overall Change (metres)Date (dd/mm/yy)Level of desaturation Physio AssessmentDate (dd/mm/yy)Level of desaturation Pre-Treatment 1Date (dd/mm/yy)Pre-Treatment 2Date (dd/mm/yy)Post-TreatmentLevel of desaturation Overall ChangeDate (dd/mm/yy)MRC Physio AssessmentDate (dd/mm/yy)MRC Pre-Treatment 1Date (dd/mm/yy)Pre-Treatment 2Date (dd/mm/yy)Post-TreatmentMRC Overall ChangeDate (dd/mm/yy)FEV1/FVCPhysio AssessmentDate (dd/mm/yy)FEV1/FVC Pre-Treatment 1Date (dd/mm/yy)Pre-Treatment 2Date (dd/mm/yy)Post-TreatmentFEV1/FVC Overall ChangeDate (dd/mm/yy)FEF 25%-75% Physio AssessmentDate (dd/mm/yy)FEF 25%-75% Pre-Treatment 1Date (dd/mm/yy)Pre-Treatment 2Date (dd/mm/yy)Post-TreatmentFEF 25%-75% Overall ChangeDate (dd/mm/yy)BP Physio AssessmentDate (dd/mm/yy)BP Pre-Treatment 1Date (dd/mm/yy)Pre-Treatment 2Date (dd/mm/yy)Post-TreatmentBP Overall ChangeDate (dd/mm/yy)HR Physio AssessmentDate (dd/mm/yy)HR Pre-Treatment 1Date (dd/mm/yy)Pre-Treatment 2Date (dd/mm/yy)Post-TreatmentHR Overall ChangeDate (dd/mm/yy)ScaleImpairmentActivity LimitationParticipation RestrictionDistress ClientDistress CarerScaleImpairmentActivity LimitationParticipation RestrictionDistress ClientDistress CarerScaleImpairmentActivity LimitationParticipation RestrictionDistress ClientDistress CarerDate (dd/mm/yy)ScaleImpairmentActivity LimitationParticipation RestrictionDistress ClientDistress CarerScaleImpairmentActivity LimitationParticipation RestrictionDistress ClientDistress CarerScaleImpairmentActivity LimitationParticipation RestrictionDistress ClientDistress CarerDate (dd/mm/yy)ScaleImpairmentActivity Limitation

ABUHB00306/12/53ABUHB64Female10/07/17NO10/07/17Yes10/07/17Yes128.07/10/17Yes10/07/17Yes10/07/17Yes10/07/17YesN/AYesPrimarySCLC2a002a1a0NO0NO11/08/17Yes03/08/1700114503/08/1700114503/08/1711139018003/08/175203/08/171.6103/08/170.0031/12/99-100.0031/12/990.0031/12/990.000.0003/08/1720.0631/12/990.0031/12/990.0031/12/990.000.0003/08/17n/a31/12/9931/12/9931/12/990.00%03/08/17031/12/9931/12/9931/12/99003/08/1726.531/12/9931/12/9931/12/99(27)03/08/1720.931/12/9931/12/9931/12/99(21)03/08/172031/12/9931/12/9931/12/99(20)03/08/17n/a31/12/9931/12/9931/12/990.000003/08/170.831/12/9931/12/9931/12/99(0.80)03/08/1731031/12/9931/12/9931/12/99-310.003/08/171031/12/9931/12/9931/12/99(10)03/08/17231/12/9931/12/9931/12/99(2)03/08/171.5831/12/9931/12/9931/12/99-1.603/08/1731/12/9931/12/9931/12/990%03/08/17134/9631/12/9931/12/9931/12/9903/08/177831/12/9931/12/9931/12/99(78)8/3/17AusTOMS Scale 133AusTOMS Scale 443AusTOMS Scale 733

ABUHB00814/08/44ABUHB73Male7/31/17Yes7/31/17Yes7/31/17Yes7/31/17Yes7/31/17Yes7/31/17NoN/A7/31/17NoYesPrimarySCLC9/1/17Yes8/17/170011458/17/171012608/17/1700114515017/08/1771.58/17/171.718/17/1708/17/17n/a8/17/1708/17/17288/17/1725.18/17/17228/17/17n/a8/17/170.968/17/173508/17/1758/17/1728/17/172.528/17/17115/648/17/17568/17/17AusTOMS Scale 444334AusTOMS Scale 1044334AusTOMS Scale 1243334

ABUHB00204/06/50ABUHB67Male6/22/17Yes6/22/17Yes6/22/17Yes156.06/22/17Yes6/22/17Yes6/16/17YesN/A6/22/17YesYesPrimaryNSCLC- Adenocarcinoma3303333008/18/17Yes7/20/1721251707/20/172024857/20/1720249034520/07/1772727/20/171.7907/20/17n/a8/17/17N/a7/20/1718/17/1707/20/17288/17/1728.87/20/1721.98/17/1725.67/20/17168/17/17207/20/17n/a8/17/17N/a8/20/1718/17/170.937/20/171008/17/17807/20/1728/17/1707/20/1748/17/1747/20/172.43/3.737/20/17112/758/17/17108/687/20/17958/17/17867/20/17AusTOMS Scale 222344AusTOMS Scale 433344AusTOMS Scale 5233448/17/17AusTOMS Scale 222443AusTOMS Scale 434443AusTOMS Scale 524443

ABUHB00522/02/39ABUHB78Female7/5/17No7/5/17No7/5/17Yes122.07/5/17Yes7/5/17Yes7/5/17YesN/A05/047/2017NoYesPrimarySCLC4244228/21/17Yes8/3/170022758/3/171023858/3/171023802406003/08/176061.58/3/171.78/3/1718/3/17278/17/1726.88/3/17218/17/1720.28/3/17148/17/1717n/aN/a8/3/170.848/17/170.848/3/172408/17/172908/3/1718/17/1728/3/1738/17/1728/3/171.6/2.98/3/17159/778/17/17151/718/3/17678/17/17658/3/17AusTOMS Scale 122224AusTOMS Scale 433224AusTOMS Scale 10332248/17/17AusTOMS Scale 122234AusTOMS Scale 434234AusTOMS Scale 1033234

CV000130/12/34CVUHB82Male9/11/17No9/11/17Yes9/11/17No105.09/11/17Yes9/11/17Yes9/11/17No9/11/17N/A9/11/17NoNoOtherYes9/21/170044909/21/170033709/21/1700112080906021/09/1765.2682.89/21/171.7029.69/21/179.621/09/1722.510/30/1723.51.09/21/1720.710/30/1720.1-0.69/21/17110/30/170-19/21/1728.510/30/1728.509/21/1717.810/30/1717.7-0.19/21/1718.810/30/1718-0.89/21/1751.100010/30/1753.90002.80009/21/179/21/174869/30/1749049/21/172%9/30/173%1%9/21/1719/30/17109/21/171.67/3.13n/a9/21/17150/819/30/17145/759/21/17629/30/176429/21/17AusTOMS Scale 25454

CV000202/01/41CVUHB76Male9/11/17No9/11/17Yes9/11/17No9/11/17Yes9/11/17Yes9/11/17No9/11/17NoNo9/11/17000009/11/17000009/11/170000006060

CV000324/09/46CVUHB71Male9/26/17No9/26/17No10/3/17Yes144.09/26/17Yes9/26/17Yes9/26/17Yes9/26/17N/A9/26/17YesYesPrimaryNSCLC- Squamous Cell Cancer2a2010/6/17Yes9/18/172013609/18/172013509/18/17101220901006018/09/1789.69/18/171.773.79/18/173.718/09/1728.69/18/1729.59/18/1709/18/17359/18/1728.69/18/1734.99/18/1759.70009/18/171.129/18/17320n/an/a9/18/173%9/18/1739/18/17N/A9/18/17N/A9/18/17170/839/18/17839/18/17AusTOMS Scale 24445

CV000428/01/38CVUHB79Female8/21/17No8/21/17Yes8/21/17No89.08/21/17Yes8/21/17Yes9/11/17No9/11/17NoYesPrimaryNSCLC- Squamous Cell Cancer301b301b9/28/17Yes9/21/170022409/21/171124809/21/171124801001506021/09/1756.457.61.29/21/171.65199/21/17921/09/1720.79/21/1721.10.49/21/1731.110/12/1731-0.19/21/17110/12/170-19/21/172010/12/172339/21/171110/12/1717.96.99/21/1716.410/12/17170.69/21/1738.400010/12/1739.50001.10009/21/17N/A10/12/17N/A9/21/17unable to untake walktest due to being too unwell10/12/17N/An/a9/21/17N/A10/12/17N/A9/21/17310/12/17308/21/172.01/3.1310/12/178/21/170.28 - 3.6910/12/179/21/17N/A10/12/17N/A9/21/17N/A10/12/17N/A9/21/17AusTOMS Scale 8223210/12/17AusTOMS Scale 83332

CV000522/02/43CVUHB74Male9/19/17No9/19/17Yes9/19/17yes9/19/17yes9/19/17Yes9/19/17Yes9/19/17YesNo9/18/17000009/18/17000009/21/170000003060

CV000628/04/50CVUHB67Male9/18/17No9/18/17Yes9/18/17Yes138.09/18/17No9/18/17Yes9/18/17NoN/A9/18/17NoYesPrimaryNSCLC- Adenocarcinoma2a21b22011/8/17Yes9/21/1700331409/21/1710341309/21/17001120130906021/09/178583-29/21/171.6513.49/21/173.421/09/1731.230.4-0.89/21/1734.610/5/1735.10.59/21/17010/5/17009/21/17309/21/1745.79/21/1733.19/21/1755.200010/5/1753.8000-1.40009/21/17Not taken9/21/17N/ANot able to do test due to spinae bifidan/a9/21/17N/A9/21/1729/21/17N/A9/21/17N/A9/21/17N/A9/21/17N/A9/21/17AusTOMS Scale 23333

CV000708/03/47CVUHB70Female9/18/17yes9/18/17Yes9/18/17Yes126.09/18/17Yes9/18/17Yes9/18/17NoN/A18/090/17NoYesPrimaryNSCLC- Adenocarcinoma2a002a0011/21/17Yes9/25/170033709/25/1720351009/25/17102370160806019/10/1762.562.60.110/19/171.67210/19/17219/10/1722.422.40.010/19/173511/6/1739.24.29/25/17011/6/170010/19/1725.511/6/1724.5-110/19/1722.0511/6/1720.42-1.6310/19/171011/6/1712.52.510/19/1740.200011/6/1737.8000-2.400010/19/17Not taken9/25/17410/19/175511/6/171701669/25/170%10/19/172%11/6/172%2%9/25/17510/19/17211/6/172-39/18/171.59/2.6710/27/171.57/2.8510/27/171.57/2.859/25/17N/A10/27/170.17-2.1310/27/170.17-2.139/25/17N/A10/19/17123/8411/6/17123/849/25/17N/A10/19/177511/6/17759/25/17AusTOMS Scale 423233AusTOMS Scale 733233AusTOMS Scale 122223311/6/17AusTOMS Scale 433343AusTOMS Scale 732343AusTOMS Scale 1222233

ABUHB00113/04/47ABUHB70Male7/14/17Yes7/14/17Yes7/14/17Yes145.07/14/17Yes7/14/17Yes7/14/17Yes6/26/17NON/AyesPrimary2bx1a2bx1aYes7/20/172013607/20/172013757/20/178119180315BG Frailty20/07/17121.5119.77/20/171.7220/07/17n/a9/1/17n/a7/20/1709/1/1707/20/1735.59/1/17n/a7/20/1722.59/1/17n/a7/20/17269/1/17n/a7/20/17n/a7/20/170.967/20/173507/20/17-9%7/20/1727/20/171.1/1.4 73%7/20/17165/727/20/17797/20/17AusTOMS Scale 444331AusTOMS Scale 743431AusTOMS Scale 2444319/21/17AusTOMS Scale 434332AusTOMS Scale 733332AusTOMS Scale 234432

ABUHB00908/06/50ABUHB67MaleN/AN/AN/A8/16/17Yes8/16/17No8/16/17Yes8/16/17NoNoFirst line advice and support8/17/171012558/17/172013658/17/1710125517517/08/1787.58/17/171.668/17/1728/17/1735.58/17/1730.88/17/17318/17/171.148/17/173208/17/172%8/17/1728/17/172.30/2.988/17/17158/758/17/17878/17/17AusTOMS Scale 244433

ABUHB01031/07/45ABUHB72Male8/9/17no8/9/17no8/9/17Yes139.08/9/17Yes8/9/17yes8/3/17non/a8/3/17noyesPrimaryNSCLC- Squamous Cell Cancer401a401ayes8/24/170011158/24/172013658/24/1720136013024/08/17598/24/171.78/24/1718/24/17268/24/1723.18/24/17268/24/170.888/28/17AusTOMS Scale 433334AusTOMS Scale 733334AusTOMS Scale 1023334

ABUHB01625/01/49ABUHB68Female9/15/17Yes9/15/17Yes9/15/17Yes9/15/17Yes9/15/17Yes9/15/17YesN/AN/A10/8/17yes9/28/170011459/28/170011459/28/1710125514528/09/17639/28/171.589/28/173-7%28/09/17249/28/1734.529/28/1709/28/1730.59/28/1722.99/28/17189/28/1739.00009/28/170.889/28/173209/28/173%9/28/1729/28/171.89/2.55 104%9/28/17135/719/28/17799/28/17AusTOMS Scale 133333AusTOMS Scale 422333AusTOMS Scale 1033333

CV000806/01/57CVUHB60Male10/2/17Yes10/2/17Yes10/2/17Yes152.010/2/17Yes10/2/17Yes10/2/17Yes9/1/17Yes8/31/17YesNoOtherYes10/5/1700336010/5/1700112010/5/1700112040806005/10/177510/5/171.78Unknown10/5/17Unknown05/10/1723.710/5/171910/5/17110/5/172910/5/172710/5/1729.710/5/1760.400010/5/17Not taken10/5/17380n/an/a10/5/173%10/5/17110/5/173.59/4.9710/2/170.87 - 6.9210/5/17171/10710/5/17979/28/17AusTOMS Scale 14444

CV000913/08/42CVUHB75Male9/28/17No9/28/17Yes9/28/17No126.09/28/17Yes9/28/17Yes9/29/17NoN/A9/28/17NoNo10/2/170000010/2/170000010/2/170000003030

CV001012/09/56CVUHB61Male10/4/17No10/4/17No10/4/17Yes143.010/4/17No9/13/17Yes9/13/17YesN/A10/4/17NoYesPrimaryNSCLC- Squamous Cell Cancer3X012/29/17Yes10/5/174061021010/5/1700223010/5/17001120801006005/10/178383.40.410/5/171.727Unknown10/5/17Unknown05/10/1727.828.00.210/5/17N/A10/5/17010/5/17N/A10/5/17N/A10/5/17N/A10/5/17N/A10/5/17Not taken10/5/1757012/11/175902010/5/175%12/11/173%-2%10/5/17112/11/171010/2/172.22/3.3812/11/172.10/3.2710/2/170.35 - 4.1710/5/17164/9312/11/17155/8710/5/178312/11/1775-810/5/17AusTOMS Scale 43344

CV001118/02/35CVUHB82Male9/24/17No9/24/17Yes9/24/17No129.09/28/17No9/28/17No9/24/17NoN/A9/24/17NoYesNSCLC- Adenocarcinoma431b431bYes10/9/1700112010/9/1700112010/9/1721149080806009/10/179410/9/171.67unknown10/9/17unknown09/10/1733.710/9/1738.310/9/17010/9/172810/9/1724.910/9/1718.510/9/1757.700010/9/17N/A10/9/17N/An/an/a10/9/17N/A10/9/175N/AN/AN/AN/A10/9/17AusTOMS Scale 21113AusTOMS Scale 51113AusTOMS Scale 71113

CV001211/02/60CVUHB57Female8/30/17Yes8/30/17Yes8/30/17Yes127.08/30/17Yes8/30/17Yes8/30/17YesN/A8/30/17YesYesPrimaryNSCLC- Adenocarcinoma331b11/17/17Yes10/5/1700114010/5/1710347010/5/1710232070806005/10/1770.270-0.210/5/171.61unknown10/5/17unknown05/10/172727.00.010/5/17N/A10/5/17011/23/170010/5/17N/A10/5/17N/A10/5/17N/A10/5/17N/A10/5/17N/A10/5/17No 6 walk test due to dizzinessn/an/a10/5/17N/A10/5/17110/5/17N/A10/5/17N/A10/5/17N/A10/5/17N/A10/5/17AusTOMS Scale 13334

CV001316/01/40CVUHB77Male9/18/17No9/18/17Yes9/18/17No128.09/18/17No9/18/17No9/18/17NoN/A9/18/17YesYesPrimaryNSCLC- Adenocarcinoma2a0012/19/17Yes10/12/17205717010/12/1700112010/12/170000060806012/10/1784.883-1.810/12/171.77Unknown10/12/17Unknown12/10/172726.5-0.510/12/17N/A10/12/17010/12/17N/A10/12/17N/A10/12/17N/A10/12/17N/A10/12/17N/A10/12/1723011/27/17220-1010/12/17Plus 4%11/27/17Plus 4%0%10/12/17211/27/171-19/18/172.03 /3.7611/27/171.98/3.569/18/170.15-2.5710/12/17136/7311/27/17145/7010/12/176911/27/17690

CV001417/04/36CVUHB81Female10/9/17Yes10/9/17Yes10/9/17Yes124.010/6/1710/6/17Yes10/6/17YesN/A10/6/17YesNo10/9/170000010/9/170000010/9/170000003030

CV001501/10/50CVUHB67Male10/25/17Yes10/25/17Yes10/25/17Yes135.0N/AN/AN/A10/25/17NoN/ANoOtherArea of inflammation, scan to be undertaken in 3 monthsw time.Yes10/12/1700225010/12/1700112012/12/170000030506012/10/1710110/12/171.77unknown10/12/17unknown12/10/1732.210/12/1710/12/17010/12/17N/A10/12/17N/A10/12/17N/A10/12/17N/A10/12/17N/A10/12/17350n/an/a10/12/172%10/12/17010/9/173.48/4.5210/9/17n/a10/12/17156/6810/12/1768

ABUHB00630/01/60ABUHB56Femalen/an/an/a7/7/17YesN/AN/AN/AN/AYes2aYes8/10/178/10/178/10/1710/08/1777768/10/171.558/10/1709/21/1708/10/17379/21/17378/10/1732.49/21/1728.88/10/17189/21/17218/10/170.889/21/170.958/10/171009/21/171608/10/173%9/21/170%8/10/1749/21/1748/10/171.52/1.978/10/17136/759/21/17115/748/10/17979/21/17898/10/17AusTOMS Scale 133333AusTOMS Scale 423333AusTOMS Scale 723333

ABUHB00717/08/48ABUHB69Male7/5/17No7/5/17Yes7/5/17No110.07/5/17Yes7/5/17No7/5/17Yes7/5/17yes7/5/17NoYesPrimary32023220m/aYes8/10/178/10/178/10/1710/08/171081088/10/171.878/10/1709/7/1708/10/1736.59/7/17358/10/1725.59/7/1727.48/10/17269/7/17278/10/170.969/7/170.958/10/173909/7/173909/7/1768/10/1729/7/1728/10/172.43/4L9/7/172.0/3.648/10/1796/649/7/17102/658/10/17679/7/17688/10/17AusTOMS Scale 433334AusTOMS Scale 734334AusTOMS Scale 1034334

ABUHB01214/06/32ABUHB85Male8/29/17no8/29/17no8/29/17no108.08/29/17no8/29/17yes8/29/17NoyesPrimary40400Yes9/7/179/7/1730251059/7/17207/09/1755549/7/171.639/7/1720.89/7/17210/12/1719/7/172610/12/1724.59/7/1722.510/12/1721.49/7/171910/12/17169/7/1742.80009/7/170.919/7/173409/7/17310/12/1739/7/17114/7910/12/17106/719/7/179310/12/171079/7/17AusTOMS Scale 133434AusTOMS Scale 433434AusTOMS Scale 1033434

CV001630/10/43CVUHB73Female10/31/17Yes10/31/17Yes10/31/17Yes149.010/31/17YesN/A10/31/17Yes10/31/17YesN/AYesPrimaryNSCLC- Adenocarcinoma1a0011/8/17Yes10/16/17003310010/16/1700113010/16/170000040706016/10/176810/16/171.62010/16/17016/10/1726.310/16/1738.810/16/17010/16/172910/16/172310/16/1721.510/16/1742.200010/16/17Not taken10/16/1741010/31/174201010/16/173%10/31/175%2%10/16/17110/31/171010/11/170.86/1.810/11/170.18-0.7710/16/17142/7510/31/17138/7810/16/177710/31/178912

ABUHB01328/11/42ABUHB74FemaleYesPrimary3N03N0yes9/14/179/25/179/14/1725/09/1747499/25/171.529/25/17010/12/1709/14/17n/a10/12/172509/14/17n/a10/12/172%9/14/17310/12/1749/14/171.329/14/17112/6410/12/17168/809/14/1713610/12/17569/14/17AusTOMS Scale 143333AusTOMS Scale 433333AusTOMS Scale 1033333

ABUHB01523/10/49ABUHB67Female10/6/17No10/6/17no10/6/17yes135.010/6/17yes10/6/17yes10/6/17yesN/A10/6/17n-28no2b20yes9/28/1719/28/179/28/1728/09/17919/28/171.679/28/174.20%28/09/1732.69/28/1744.39/28/1709/28/17339/28/17249/28/17169/28/1747.80009/28/170.829/28/173409/28/1769/28/1729/28/172.05/3.0 90%/11%9/28/17149/959/28/17819/28/17AusTOMS Scale 133333AusTOMS Scale 433333AusTOMS Scale 1033333

ABUHB01924/05/37ABUHB80Male9/18/17no9/18/17yes9/18/17yes140.09/18/17Yes9/18/17Yes9/18/17YesNo431ayes10/5/1710/5/1710/5/1710/5/176210/5/171.610/5/17010/5/1727.510/5/1724.310/5/1718

ABUHB02122/05/46ABUHB71Female10/10/17Yes10/10/17Yes10/10/17Yes134.010/10/17Yes10/10/17Yes10/10/17YesYes10/12/1710/12/1710/12/1712/10/1762.510/12/171.6510/12/1733.110/12/17010/12/1726.510/12/1722.410/12/171010/12/1741.700010/12/173710/12/172%10/12/17110/12/172.05/2.7010/12/17130/7710/12/177510/12/17AusTOMS Scale 143333AusTOMS Scale 433333AusTOMS Scale 1033333

ABUHB02218/11/41ABUHB75Male10/5/17Yes10/5/17Yes10/5/17Yes10/5/17Yes10/5/17Yes10/5/17No8/22/17n-34yesPrimaryNSCLC- Squamous Cell Cancer4140x11/8/17yes10/12/17211418010/12/1710126010/12/171012557012/10/17707210/12/171.7810/12/173.110/12/1723.610/12/17111/3/17010/12/172710/12/1723.810/12/173210/12/1753.400010/12/1746010/12/171%10/12/17110/12/171.6 53% /25 64%10/12/178310/12/178110/12/17AusTOMS Scale 133332AusTOMS Scale 433332AusTOMS Scale 103333211/7/17AusTOMS Scale 133333AusTOMS Scale 433333AusTOMS Scale 1033333

CV001716/10/41CVUHB75Male10/10/17No10/10/17Yes10/10/17No122.010/10/17Yes10/10/17Yes10/11/17NoN/A10/10/17NoYesPrimaryNSCLC- Adenocarcinoma221b12/5/17Yes10/16/1700113010/16/1720135011/2/1700222060806016/10/1781.410/16/171.798.510/16/178.516/10/1725.410/16/1728.510/16/17110/16/1731.510/16/1727.710/16/1732.510/16/1757.800010/16/17Not taken10/16/17N/An/an/a10/16/17N/A10/16/170n/an/a10/16/17N/A10/16/17N/A11/2/17AusTOMS Scale 54334

CV001808/06/46CVUHB71Female9/26/17Yes9/26/17Yes9/26/17Yes141.0N/A9/26/17Yes9/26/17YesN/A9/26/17YesYesPrimaryNSCLC- Adenocarcinoma2a30Yes10/19/17004415010/19/1700225010/19/170000060806019/10/1757.6580.410/19/171.52010/19/17019/10/1724.925.10.210/19/1730.311/27/1729.6-0.710/19/17011/27/170010/19/172711/27/1726-110/19/1723.211/27/1721.3-1.910/19/1720.111/27/1719.4-0.710/19/1739.800011/27/1740.50000.700010/19/17Not taken10/19/1734011/27/173703010/19/179%11/27/171%-8%10/19/17111/27/171010/19/171.02/1.9411/21/170.88/1.8210/19/17n/a11/21/170.93-0.8910/19/17115/7111/27/17130/6810/19/178211/27/17897

CV001919/10/46CVUHB74Female10/16/17Yes10/16/17Yes10/16/17Yes146.010/16/17Yes10/16/17Yes10/16/17Yes10/16/17YesN/AYesPrimary1b0012/4/17Yes10/23/17005519010/23/1700227010/23/170000080806023/10/1762.463.20.810/23/171.62010/23/17023/10/1723.924.10.210/23/1736.311/30/1736.3010/23/17011/30/170010/23/173111/30/1731010/23/1726.911/30/1726.9010/23/1719.511/30/1722.42.910/23/1739.500011/30/1740.00000.500010/23/17Not taken10/23/1714011/30/171602010/23/1714%11/30/172%-12%10/23/17311/30/172-110/23/170.87/2.5211/30/170.91/2.4010/23/170.10-0.5711/30/170.2410/23/17119/7411/30/17130/7810/23/178511/30/1777-8

CV002019/09/26CVUHB87Male6/9/17No6/9/17Yes6/9/17Yes146.06/9/17Yes6/9/17No6/9/17YesYesPrimaryNSCLC- AdenocarcinomaYes10/23/1710013010/23/1720356010/23/170000030606023/10/177510/23/171.719.110/23/179.123/10/1725.610/23/1734.210/23/17110/23/172710/23/1724.210/23/1728.610/23/1749.400010/23/17Not taken10/23/17215n/an/a10/23/17Plus 12%10/23/172N/AN/A10/23/17117/6610/23/1772

CV002108/12/55CVUHB61Male9/25/17No9/25/17Yes9/25/17Yes145.09/25/17Yes9/25/17yesN/A9/25/17YesYesPrimaryNSCLC- Squamous Cell Cancer1b1011/13/17Yes10/19/17004415010/19/1700224010/19/170000060807019/10/1765.667.82.210/19/171.702010/19/17011/9/17019/10/1722.611/9/1723.40.810/19/1717.311/9/1716.4-0.910/19/17011/9/170010/19/172711/9/1727.50.510/19/1724.511/9/1725.20.710/19/1735.511/9/1732.1-3.410/19/1753.800011/9/1756.20002.400010/19/17Not taken10/19/1750011/9/175505010/19/175%11/9/171%-4%10/19/17111/9/17109/25/173.3/4.89/25/170.47- 6.8810/19/17121/8011/9/17121/8810/19/177611/9/17782

CV0022CVUHBNo10/23/170000010/23/170000010/23/170000004040

CV002317/11/62CVUHB54Female10/13/17No10/13/17No10/13/17No100.010/13/17Yes10/13/17Yes10/13/17NoN/A10/13/17NoYesPrimaryNSCLC- Adenocarcinoma2a30Yes10/26/17203518010/26/17103410011/2/1700112070706026/10/1759.263.84.610/26/171.6263.110/26/173.126/10/1722.424.11.710/26/1733.311/27/1735.92.610/26/17011/27/170010/26/1725.511/27/1724-1.510/26/1719.511/27/1716.83-2.6710/26/179.911/27/1718.9910/26/1739.200011/27/1740.60001.400010/26/17Not taken10/26/1735011/27/1754019010/26/173%11/27/176%3%10/26/17211/27/1720N/AN/A11/2/17142/8111/27/17156/8110/26/178311/27/1791811/2/17AusTOMS Scale 24444

CV002423/08/47CVUHB70Female10/23/17Yes10/23/17Yes10/23/17Yes129.010/23/17Yes10/23/17Yes10/23/17YesN/A10/23/17NoYesPrimaryNSCLC- Squamous Cell Cancer1a0011/28/17Yes10/26/17003312010/26/1700113010/26/170000060906026/10/179010/26/171.6010/26/17026/10/1734.910/26/1746.110/26/17010/26/173210/26/1725.110/26/1723.810/26/1748.100010/26/17Not taken10/26/17350Nov-17330-2010/26/175%Nov-172%-3%10/26/171Nov-171010/26/172.03/3.0010/26/170.31-3.8911/2/17135/7410/26/1782Nov-17864

CV002525/04/48CVUHB69Male10/27/17No10/27/17Yes10/27/17No127.010/27/17Yes10/27/17Yes10/23/17YesN/A10/23/17YesNoPrimaryNSCLC- Adenocarcinoma2a0012/22/17Yes10/30/17005513010/30/1700448010/30/17001130501206030/10/176870.22.210/30/171.702510/30/17530/10/1723.424.20.810/30/1719.711/27/1720.112/11/1720.10.410/30/17011/27/17012/11/170010/30/172911/27/173012/11/1730110/30/1725.911/27/172812/11/17282.110/30/1741.111/27/1743.712/11/1743.72.610/30/1754.100011/27/1755.800012/11/1755.80001.700010/30/17Not taken10/30/1755011/27/175702010/30/171%11/27/171%0%10/30/17111/27/171010/23/173.16/4.6212/11/173.11/4.5610/30/170.48-7.9810/30/17132/8511/27/17171/9810/30/175611/27/17731710/30/17AusTOMS Scale 13443

CV002623/01/42CVUHB75Female10/2/17No10/2/17Yes10/2/17No108.0N/AN/AN/AN/AN/AYesPrimaryNSCLC- Adenocarcinoma2b00Yes10/26/17003313010/26/1700339010/26/1700000401006026/10/1739.640.40.810/26/171.6unknown10/26/172826/10/1715.511/20/1715.80.310/26/1727.111/20/1728.31.210/26/17411/20/174010/26/172111/20/1721.50.510/26/1718.211/20/1718.360.1610/26/1714.211/20/1714.80.610/26/1728.200011/20/1728.70000.500010/26/17Not taken10/26/17011/20/17909010/26/17N/A11/20/17010/26/17311/20/172-110/2/170.93/2.3310/2/170.16-0.8510/26/17N/A11/20/17103/6810/26/17N/A11/20/17110

CV0027Not Lung CancerCVUHBNo10/23/170000010/23/170000010/23/170000004030

CV002812/12/37CVUHB79Female10/30/17No10/30/17Yes10/30/17Yes115.010/30/17Yes10/30/17Yes10/30/17YesN/A10/30/17YesYesPrimary1b0Yes11/2/1700229011/2/1720247011/2/1700112070806002/11/1739.640.81.211/2/171.47unknown11/2/1715.302/11/1718.318.90.611/2/1729.512/14/1730.61.111/2/17412/14/172-211/2/1720.512/14/1720.5011/2/1717.0512/14/1718.261.2111/2/1715.412/14/1714.9-0.511/2/1727.600012/14/1728.00000.400011/2/17Not taken11/2/1729012/14/173506011/2/171%12/14/171%0%11/2/17312/14/173010/30/170.93/1.8210/30/170.12-0.9611/2/17138/7212/14/17127/6611/2/176612/14/1764-211/2/17AusTOMS Scale 23333N/A

CV002922/02/60CVUHB57Male10/3/17No10/30/17No10/30/17Yes147.010/30/17Yes10/30/17Yes10/30/17YesN/A10/30/17YesYesPrimaryNSCLC- Adenocarcinoma2a0011/28/17Yes11/2/17003312011/2/1700114011/2/1700227080906002/11/1758.260.2211/2/171.727.611/2/177.602/11/1719.711/27/1720.30.611/2/1715.911/27/1715.8-0.111/2/17211/27/171-111/2/172511/27/1725011/2/1722.511/27/1722.60.111/2/174511/27/1742-311/2/1748.400011/27/1750.20001.800011/2/17Not taken11/2/1746011/27/17410-5011/2/174%11/27/171%-3%11/2/17111/27/171010/30/172.71-4.0211/27/172.66-4.0810/30/170.49-4.9411/27/170.34-4.8311/2/17124/8511/27/17105/7211/2/176711/27/17851811/2/17AusTOMS Scale 1012222

CV003017/06/46CVUHB71Male10/10/17Yes10/10/17Yes10/10/17Yes134.010/10/17Yes10/10/17Yes10/10/17NoN/A10/10/17NoNoYes11/2/1700116011/2/1700114011/2/1700112040806002/11/1783.211/2/171.83011/2/17002/11/1724.811/2/1724.611/2/17011/2/1729.511/2/1725.711/2/1736.711/2/1762.400011/2/17Not taken11/2/17490n/an/a11/2/177%11/2/171N/AN/A11/2/17163/8311/2/177011/2/17AusTOMS Scale 433443

ABUHB02321/09/34ABUHB82Male10/10/17N/A10/10/17N/A10/10/17N/A10/10/17Yes10/10/17Yes10/10/17yes5/25/17NoN/ANoyes10/12/1700112510/12/1700114510/12/172013557012/10/1773.510/12/171.6310/12/17010/12/172610/12/172610/12/172610/12/17n/a10/12/17n/a10/12/17110/12/171.72/2.0610/12/17136/6810/12/176210/12/17AusTOMS Scale 123333AusTOMS Scale 223333AusTOMS Scale 423333

ABUHB02407/09/52ABUHB65Male10/6/17n/a10/6/17N/A10/6/17N/A10/6/17No10/6/17No10/6/17N/A10/6/17NoN/AYesPrimaryNSCLC- Squamous Cell Cancer310yes10/12/1710/12/1710/12/1710/12/179510/12/171.8310/12/17010/12/1730.510/12/1726.210/12/17110/12/1714010/12/17710/12/17410/12/172.65/5.4710/12/17141/7510/12/177210/12/17AusTOMS Scale 122222AusTOMS Scale 422222AusTOMS Scale 1022222

CV003109/07/41CVUHB76Female11/1/17No11/1/17No11/1/17No81.011/1/17Yes11/1/17Yes11/1/17NoN/AN/AYesPrimaryNSCLC- Adenocarcinoma2b1012/5/17Yes11/6/1700116011/6/1700116011/6/1710125060806006/11/175511/6/171.62613.411/6/1713.406/11/1720.811/6/1737.311/6/17211/6/172511/6/1723.311/6/1710.611/6/1734.200011/6/17Not taken11/6/17380n/an/a11/6/174%11/6/17311/6/172.06/3.0811/6/170.25-5.1711/6/17109/6311/6/177311/6/17AusTOMS Scale 101122

CV003201/06/50CVUHB67FemaleN/AN/AN/AN/AN/A7/20/17Yes8/3/17YesN/AYesPrimaryNSCLC- Adenocarcinoma1a0012/20/17Yes11/9/1700227011/9/1700115011/9/170000040806009/11/1765.465.2-0.211/9/171.57011/9/17009/11/1726.526.5-0.011/9/1735.112/4/1734.9-0.211/9/17012/4/170011/9/1726.512/4/17270.511/9/1724.912/4/1725.70.811/9/1720.312/4/1722.72.411/9/1742.100012/4/1742.20000.100011/9/17Not taken11/9/1742012/4/174402011/9/174%12/4/173%-1%11/9/17112/4/171011/6/171.63/3.2511/6/170.30-1.7411/9/17131/8312/4/17152/9211/9/177412/4/178612

CV003322/06/44CVUHB73Female11/6/17No11/6/17Yes11/6/17No167.011/6/17YesN/A11/6/17YesN/A11/6/17NoYesPrimaryNSCLC- Adenocarcinoma2a00Yes11/9/1700112011/9/1700112011/9/170000020406009/11/176511/9/171.524.411/9/174.409/11/1728.111/9/1743.411/9/17011/9/172511/9/1723.411/9/1717.511/9/1736.500011/9/17Not taken11/9/17N/An/an/a11/9/17N/A11/9/17311/6/170.67/1.5111/6/170.13-0.5511/9/17N/A11/9/17N/A

CV003424/04/47CVUHB70Female11/6/17No11/6/17Yes11/6/17No174.0N/A11/6/17Yes11/6/17YesYes11/6/17NoNoYes11/9/1700112011/9/1700112011/9/170000020406009/11/174711/9/171.6011/9/17009/11/1718.311/9/1727.311/9/17211/9/1724.511/9/1722.711/9/1718.911/9/1733.800011/9/17Not taken11/9/17160n/an/a11/9/17011/9/172N/AN/A11/9/17103/6511/9/1753

ABUHB02027/05/56ABUHB61Male10/11/17No10/11/17yes10/11/17yes132.010/11/17no10/11/17yes10/11/17yesyesPrimarySCLC42142110/30/17Yes10/12/1710/12/17111010/12/17213103010/12/17AusTOMS Scale 133323AusTOMS Scale 433323AusTOMS Scale 1033323

ABUHB01816/04/42ABUHBFemaleyesSecondaryNSCLC- Adenocarcinoma30030010/12/17Yes10/5/1700114510/5/1700114510/5/1710126005/10/176305/10/171.6510/5/1737.110/5/1728.510/5/1721.310/5/171110/5/1737.300010/5/1734010/5/17210/5/171.55 78%10/5/17118/8310/5/177910/5/17AusTOMS Scale 133333AusTOMS Scale 333333AusTOMS Scale 43333311/7/17AusTOMS Scale 133333AusTOMS Scale 333333AusTOMS Scale 433333

ABUHB02817/07/42ABUHB75MalePrimaryNSCLC- Squamous Cell Cancer331a331a11/1/17Yes10/19/1730145510/19/1710124510/19/17721824013519/10/178710/19/171.617.410/19/1735.810/19/17110/19/173210/19/1726.910/19/172410/19/1755.500010/19/1738010/19/171110/19/17210/19/172.1/310/19/17138/7610/19/176610/19/17AusTOMS Scale 133334AusTOMS Scale 423334AusTOMS Scale 122333411/9/17AusTOMS Scale 13333AusTOMS Scale 43333AusTOMS Scale 123333

CV003522/09/30CVUHBNo11/16/170000011/16/170000011/16/170000004030

CV003605/09/65CVUHB52Female12/19/17No12/19/17No12/19/17Yes134.012/19/17Yes12/19/17Yes12/19/17NoN/A12/19/17NoYesPrimaryNSCLC- Squamous Cell Cancer42012/29/17Yes11/23/1700113011/23/1720356011/23/1710123090806023/11/1745.811/23/171.5492011/23/172023/11/171911/23/1724.311/23/17311/23/172411/23/1721.811/23/1716.211/23/1734.400011/23/17370n/an/a11/23/174%11/23/17210/23/171.86/2.8310/23/171.1911/23/17152/8111/23/179911/23/18AusTOMS Scale 43332

CV003712/02/63CVUHB54Female11/20/17No11/20/17Yes11/20/17Yes137.011/20/17NoN/A11/20/17YesN/A11/20/17NoNoYes11/27/17103414011/27/1700116011/27/1700113060806027/11/1738.211/27/171.66unknown11/27/173227/11/1713.911/27/1716.511/27/17411/27/1720.511/27/1718.4611/27/1710.811/27/1731.500011/27/17Declined testn/an/a11/27/17declined test11/27/17211/20/171.3/2.811/20/170.31-1.3111/27/17declined test11/27/17declined test11/27/17AusTOMS Scale 22233

CV003812/11/49CVUHB68Female12/14/17No12/14/17No12/14/17Yes135.012/14/17No12/14/17Yes12/14/17NoN/A12/14/17NoYesSecondaryNSCLC- Squamous Cell Cancer12/15/17Yes11/30/1700119011/30/1700114011/30/170000050806030/11/1778.611/30/171.65112.711/30/1712.730/11/1728.811/30/1743.211/30/17211/30/173211/30/1729.411/30/1712.111/30/1744.400011/30/17130n/an/a11/30/173%11/30/173N/AN/A11/30/17115/7511/30/17118

CV003901/06/55CVUHBFemaleYesNo11/27/170000011/27/170000011/27/170000004040

CV004016/08/51CVUHB66FemaleYesPrimaryNSCLC- Adenocarcinoma1a003/14/18Yes12/18/17002210012/18/1700228012/18/170000030806018/12/1764.864.1-0.712/18/171.572012/18/17018/12/1726.225.9-0.312/18/17402/5/1836-412/18/1702/5/180012/18/1735.52/5/1829-6.512/18/1729.52/5/1822.7-6.812/18/1726.42/5/1824-2.412/18/1738.60002/5/1840.70002.100012/18/172602/5/183105012/18/173%2/5/185%2%12/18/1722/5/182012/18/171.44/2.512/5/181.36/2.2412/18/170.15-1.9112/18/17140/782/5/18132/7412/18/17572/5/189336

CV004129/07/37CVUHB80Male11/27/17No11/27/17Yes11/27/17No122.011/27/17Yes11/27/17Yes11/27/17NoN/A11/27/17N/AYesPrimaryNSCLC- Adenocarcinoma2a01bYes12/4/1700112012/4/1700112012/4/170000040806004/12/1775.812/4/171.7782.812/4/172.804/12/172412/4/1725.712/4/17012/4/172912/4/1726.412/4/1727.512/4/1755.900012/4/17330n/an/a12/4/173%12/4/172N/AN/A12/4/17155/8512/4/1762

CV004224/02/44CVUHB73Male12/19/17No12/19/17No12/19/17No120.012/19/17Yes12/19/17YesN/AN/A12/19/17NoYes2a00No12/4/170000012/4/170000012/4/170000003030

CV004305/02/69CVUHB48FemaleYesPrimaryNSCLC- Adenocarcinoma1b003/13/18Yes12/14/17104516012/14/1700227012/14/170000080806014/12/17112.6112.6012/14/171.676012/14/17014/12/1740.140.1-0.012/14/1750.22/8/1849.9-0.312/14/1702/8/180012/14/17422/8/1841.5-0.512/14/1733.22/8/1832-1.212/14/1727.52/8/1826.9-0.612/14/1755.90002/8/1856.20000.300012/14/174302/8/184603012/14/173%2/8/182%-1%12/14/1712/8/181012/14/17N/A2/8/182.22/2.6112/14/17N/A2/8/180.99-7.5612/14/17150/802/8/18137/7912/14/17732/8/1868-5

CV004405/04/51CVUHB66Female11/13/17Yes11/13/17Yes11/13/17Yes120.011/13/17Yes11/13/17Yes11/13/17YesN/ANoYesPrimaryNSCLC- Adenocarcinoma2a001/23/18Yes12/18/17003616012/18/1700226012/18/17000000806018/12/1781.283.11.912/18/171.5012/18/17018/12/173636.90.912/18/17491/18/1849.50.512/18/1701/18/180012/18/17371/18/1836-112/18/17361/18/1830.4-5.612/18/1712.91/18/1813.70.812/18/1741.20001/18/1842.00000.800012/18/173101/18/183605012/18/170%1/18/183%3%12/18/1721/18/181-111/13/172.08/2.731/18/181.99/2.1011/13/170.40-5.2912/18/17150/891/18/18136/8612/18/17761/18/18760

CV004509/05/42CVUHBFemaleYesNo12/21/170000012/21/170000012/21/170000004030

CV004624/08/66CVUHB51Female11/29/17No11/29/17No11/29/17Yes126.0N/AN/A11/29/17YesN/AN/AYesPrimaryNSCLC- Adenocarcinoma400Yes12/21/17002212012/21/170022801/4/18100030701006021/12/175855.6-2.412/21/171.61312/21/17321/12/1722.41/4/1821.4-1.012/21/1731.61/4/1829.6-212/21/1701/4/180012/21/1728.51/18/1827.5-112/21/1726.61/4/1825.9-0.712/21/1720.51/4/1823.42.912/21/1739.40001/4/1838.9000-0.500012/21/173601/4/18Not possible due to be too unwelln/a12/21/175%12/21/172N/AN/A12/21/17117/891/4/1882/6412/21/17791/4/1813556

CV004722/09/48CVUHB69Female12/18/17No12/18/17No12/18/17Yes118.012/18/17Yes12/18/17Yes12/18/17NoYesPrimaryNSCLC- Squamous Cell Cancer1b21bYes1/11/18000001/11/181102301/11/1801013020606011/01/1843.61/11/181.586.81/11/186.811/01/1817.51/11/1833.61/11/1831/11/18181/11/1815.31/11/18111/11/1828.60001/11/18Not possible on home visitn/an/an/a1/11/18212/18/170.92/1.8112/18/170.27-0.961/11/18108/671/11/18981/11/18AusTOMS Scale 233333AusTOMS Scale 433333AusTOMS Scale 822222

CV004827/12/44CVUHB73MaleN/AN/AN/AN/AN/AN/AN/AN/ANoYes12/21/1700224012/21/1710233012/21/170000080406021/12/1745.212/21/171.7272112/21/172121/12/1715.212/21/179.112/21/17412/21/172012/21/1717.3112/21/1732.812/21/1740.600012/21/17380n/an/a12/21/171%12/21/17112/21/172.17/3.3612/21/170.66-3.2712/21/17132/7812/21/1775

CV004902/10/45CVUHBNo12/18/170000012/18/170000012/18/170000003060

CV005004/09/56CVUHB61Male1/8/18Yes1/8/18Yes1/8/18Yes135.02/1/18Yes1/8/18Yes1/8/18YesN/A1/8/18NoYesPrimaryNSCLC- Adenocarcinoma431bYes1/11/181012401/11/180011201/11/1830142040706011/01/1880.41/11/181.67601/11/18011/01/1828.61/11/1827.91/11/1801/11/1827.51/11/1825.161/11/1834.81/11/1857.70001/11/18450Not possible due to treatment starting urgentlyn/a1/11/1811%1/11/1811/11/181.56/2.50n/a1/11/18145/871/11/18741/11/18AusTOMS Scale 444444

CV005130/03/48CVUHB69Female2/6/18No2/6/18Yes2/6/18No113.02/6/18No2/6/18Yes2/6/18NoN/A2/6/18NoYesPrimaryNSCLC- Adenocarcinoma421bYes1/11/180022701/11/1810231001/11/1800223090806011/01/1876.772.9-3.81/11/181.659.21/11/189.211/01/182826.8-1.21/11/1843.43/5/1842.1-1.31/11/1813/5/18211/11/1827.53/5/18302.51/11/1823.43/5/18251.61/11/1821.13/5/1824.23.11/11/1843.40003/5/1841.9000-1.50001/11/18420PT unable due to feeling nausea and vomitingn/a1/11/184%1/11/1811/11/181.58/2.28n/a1/11/18135/811/11/18841/11/18AusTOMS Scale 4444443/5/18AusTOMS Scale 33333

CV005216/05/60CVUHB57Female1/4/18Yes1/4/18Yes1/4/18Yes145.01/4/18No1/4/18Yes1/4/18YesN/A12/7/17NoYesPrimaryNSCLC- Adenocarcinoma421aYes1/11/180022701/11/180022601/11/1800112070806011/01/185657.31.31/11/181.6unknown1/11/18unknown11/01/182222.40.41/11/1832.32/8/1832.90.61/11/1802/8/18001/11/1825.52/8/18260.51/11/1821.12/8/1820.7-0.41/11/1820.62/8/1822.82.21/11/1837.60002/8/1838.00000.40001/11/185002/8/18490-101/11/186%2/8/183%-3%1/11/1822/8/18201/11/181.30/2.12/8/181.53/2.661/11/180.721/11/18122/672/8/18124/731/11/18722/8/187751/11/18AusTOMS Scale 13333

CV005307/06/40CVUHB77MaleYesPrimaryNSCLC- Squamous Cell Cancer320Yes1/11/18000001/11/181102401/11/18010140301206011/01/1853.41/11/181.727301/11/18unknown11/01/1817.91/11/18unable due to pacemaker1/11/1841/11/18241/11/1821.61/11/1821.61/11/18unable due to pacemaker1/11/18Not possible due to home visitn/an/a1/11/18n/a1/11/1831/11/182.2/2.51/11/181.33-4.821/11/18112/631/11/18761/11/18AusTOMS Scale 232333

CV005412/05/36CVUHB78Male1/8/18No1/8/18No1/8/18Yes158.01/8/18Yes1/8/18Yes1/8/18NoN/A2/6/18NoYesPrimaryNSCLC- Squamous Cell Cancer2a30Yes1/15/1800441501/15/182024601/15/180000060806015/01/1883.884.91.11/15/181.7901/15/18015/01/1826.226.50.31/15/1826.22/5/1826.1-0.11/15/1802/5/18001/15/18292/5/182901/15/1826.32/5/1826.80.51/15/1832.12/5/1832-0.11/15/1861.80002/5/1862.40000.60001/15/184402/5/18480401/15/1812%2/5/187%-5%1/15/1812/5/18101/8/182.51/3.391/8/180.53-6.911/15/18156/782/5/18135/921/15/18642/5/187814

CV005531/12/55CVUHB62Female1/10/18No1/10/18Yes1/10/18No110.01/10/18Yes1/10/18YesN/A1/10/18YesNoOthersurgical removal2/23/18Yes1/15/181023501/15/180033601/15/180000050806015/01/1844.443.8-0.61/15/181.65unknown1/15/1831.115/01/1816.316.1-0.21/15/1821.62/19/1820.1-1.51/15/1842/19/18401/15/1821.52/19/1821.501/15/18192/19/1818.4-0.61/15/1815.62/19/1816.10.51/15/1834.40002/19/1834.60000.20001/15/183002/19/184201201/15/1814%2/19/183%-11%1/15/1822/19/1820N/A2/19/181.78/2.12N/A1/15/1894/582/19/1882/571/15/18862/19/18871

CV005601/07/58CVUHB59Female2/14/18Yes2/14/18Yes2/14/18Yes137.02/14/18Yes2/14/18Yes12/19/17YesN/AYesPrimary3/12/18Yes1/18/1800441301/18/180022501/18/180000090806018/01/1875.474.1-1.31/18/181.62601/18/18018/01/1828.528.0-0.51/18/1835.23/5/1832.4-2.81/18/1803/5/18001/18/18333/5/1833.50.51/18/1826.13/5/1825-1.11/18/1827.63/5/1827.5-0.11/18/1848.50003/5/1849.80001.30001/18/184703/5/18520501/18/181%3/5/182%1%1/18/1813/5/18101/18/182.74/3.623/5/182.61/3.11n/a1/18/18165/793/5/18177/751/18/18823/5/18831

CV005703/02/52CVUHB65Male12/20/17No12/20/17No12/20/17Yes130.012/15/17Yes12/15/17Yes11/10/17NoN/A12/15/17NoYesPrimaryNSCLC- Adenocarcinoma411aYes1/18/1800331201/18/182035701/18/180000070806018/01/1867.61/18/181.7126.31/18/1826.318/01/1823.11/18/1824.91/18/1921/18/1827.51/18/1824.41/18/1828.41/18/1850.40001/18/18380n/an/a1/18/187%1/18/1821/18/181.90/2.39n/a1/18/18127/821/18/1898

CV005825/09/44CVUHB73Female12/27/17No12/27/17No12/27/17No110.012/27/17Yes12/27/17No12/27/17NoYesPrimaryNSCLC- Squamous Cell Cancer420Yes1/18/180011201/18/180011201/18/180000020303018/01/18441/18/181.476.41/18/186.418/01/1820.41/18/1834.41/18/1811/18/1824.51/18/1820.41/18/1813.61/18/1828.50001/18/18280n/an/a1/18/183%1/18/1821/18/181.31/1/661/18/181.181/18/18112/641/18/1888

CV005907/05/40CVUHB77Male1/25/18No1/25/18Yes1/25/18Yes155.01/18/18No1/18/18No1/25/18NoN/AYesPrimaryNSCLC- Squamous Cell CancerYes1/18/180011201/18/180011201/18/180000030306018/01/18921/18/181.77801/18/18018/01/1829.11/18/1829.71/18/1801/18/1831.51/18/1829.61/18/1833.51/18/1864.40001/18/18PT able to complete test due to balance problemsn/an/a1/18/18N/A1/18/1811/18/182.02/3.531/18/180.25-2.701/18/18180/941/18/1863

CV006013/01/55CVUHB63Male1/2/18No1/2/18Yes1/2/18No111.01/2/18Yes1/2/18Yes1/25/18YesN/A1/2/18NoYesPrimary300Yes1/22/180011201/22/180011201/18/180000020806022/01/1864.81/22/181.854unknown1/22/1814.722/01/1818.91/22/1816.61/22/1831/22/1827.51/22/1826.21/22/1833.71/22/1853.70001/22/18490n/an/a1/22/183%1/22/1821/22/181.77/2.09n/a1/22/18115/811/22/1881

CV006119/04/51CVUHB66Male1/8/18No1/8/18Yes1/8/18Yes155.01/8/18Yes1/8/18Yes1/8/18NoN/A1/9/18NoNoYes1/22/180011601/22/180011301/22/180000030806022/01/18901/22/181.76intentional weight loss1/22/18intentional weight loss22/01/18291/22/18not undertaken due to irregular heart bet1/22/1801/22/1830.51/22/1826.421/22/1830.61/22/18Not untaken due to irregular heart beat1/22/18490n/an/a1/22/182%1/22/1811/22/181.94/2.22n/a1/22/18171/821/22/1860

CV006220/11/49CVUHBMaleNo00000000000000003030

CV006312/10/42CVUHBFemaleNo00000000000000003030

CV006414/02/53CVUHB64FemaleNoYes1/25/180011201/22/180011201/25/180000040203025/01/18651/25/181.62601/25/18025/01/1824.61/25/1833.21/25/1801/25/18N/A1/25/18N/A1/25/18N/A1/25/1843.10001/25/18450n/an/a1/25/1815%1/25/182N/AN/A1/25/18145/781/25/1898

CV006514/04/35CVUHBMaleNo00000000000000003030

CV006603/05/60CVUHB57Male12/13/17No12/13/17Yes12/13/17no123.012/13/17yes12/13/17Yes12/13/17YesYesPrimaryMesotheliomaX00Yes1/22/1800221201/22/1800221201/22/18002212060806025/01/1862.260.1-2.11/25/181.701/25/18025/01/1821.520.8-0.71/25/1815.22/22/1815.80.61/25/1802/22/18001/25/1827.52/22/1825.5-21/25/1825.32/22/1823.6-1.71/25/1843.82/22/1843-0.81/25/1852.30002/22/1850.2000-2.10001/25/184402/22/185401001/25/183%2/22/1814%11%1/25/1812/22/1810n/an/a1/25/18135/702/22/18140/721/25/18682/22/1865-32/22/18AusTOMS Scale 233333

CV006729/11/34CVUHBFemaleYesNo2/1/180011302/1/1800114000000608060

CV006825/11/53CVUHBFemaleNo0000000002/1/18000003030

CV006905/06/27CVUHBMaleNo1/18/18000001/18/18000001/18/180000003030

CV007011/10/60CVUHB57Female12/18/18Yes12/18/18Yes12/18/18Yes138.012/18/17Yes12/18/17Yes12/18/17YesN/ANo3/6/18Yes1/29/1800221001/29/181023801/29/180000040806029/01/1874.61/29/181.54unknown1/29/189.629/01/1831.51/29/1842.91/29/1811/29/1832.51/29/1824.91/29/1824.31/29/1842.40001/29/18430n/an/a1/29/183%1/29/1821/29/180.97/2.61n/a1/29/18118/821/29/1876

CV007118/05/64CVUHB53Female2/14/18No2/14/18Yes2/14/18Yes130.02/14/18Yes2/14/18Yes2/14/18YesN/AYesPrimaryNSCLC- Adenocarcinoma3002/27/18Yes1/29/180022901/29/180011301/29/180000050806029/01/18941/29/181.7Unknown1/29/18Unknown29/01/1835.521/29/18411/29/1801/29/1835.51/29/18281/29/1801/29/1855.20001/29/18430n/an/a1/29/185%1/29/1811/29/182.79/3.26n/a1/29/18108/781/29/1874

CV007214/04/49CVUHB68Male1/29/18Yes1/29/18Yes1/29/18Yes144.01/29/18Yes1/29/18YesN/A1/29/18YesNomonitor in 6 months timeYes2/1/180022602/1/180022502/1/180000040806001/02/18102.42/1/181.76502/1/18001/02/1832.92/1/1830.72/1/1802/1/1834.52/1/1830.42/1/1835.32/1/1870.60002/1/18440n/an/a2/1/186%2/1/1812/1/183.16/4.34n/a2/1/18168/942/1/1879

CV007309/10/44CVUHB73Female1/29/18Yes1/29/18Yes1/29/18Yes143.01/29/18Yes1/29/18Yes1/29/18NoN/A3/3/18NoYesPrimaryNSCLC- Squamous Cell Cancer3002/26/18Yes2/5/1800221202/5/180011302/5/180000060806005/02/1864.62/5/181.67unknown2/5/189.105/02/1823.22/5/1833.22/5/1812/5/18252/5/18222/5/1823.82/5/1842.80002/5/184002/25/18420202/5/183%2/25/181%-2%2/5/1812/25/18102/5/181.83/2.812/25/181.81/2.28n/a2/5/18158/752/5/18672/25/189528

CV007405/10/63CVUHB54Female2/5/18No2/5/18Yes2/5/18Yes129.02/5/18Yes2/5/18No1/31/18Yes2/5/18NoNoYes2/8/180011402/8/180011402/8/180000040806008/02/1879.22/8/181.63unknown2/8/18unknown08/02/1829.82/8/1836.22/8/1812/8/1833.52/8/1828.32/8/1822.92/8/1850.20002/8/18420n/an/a2/8/185%2/8/1812/8/181.71/2.26n/a2/8/18125/902/8/1879

CV007524/10/44CVUHBMaleNo00000000000000003030


CV007720/07/45CVUHB72Female2/12/18No2/12/18No2/12/18Yes126.02/12/18Yes2/12/18Yes2/12/18NoN/AYesPrimaryNSCLC- Squamous Cell Cancer421bYes2/15/180011402/15/181012302/15/180000050806015/02/1879.12/15/181.5702/15/18015/02/18322/15/1847.72/15/1802/15/1835.52/15/1828.92/15/1814.12/15/1841.10002/15/18150n/an/a2/15/1815%2/15/1832/15/181.11/1.20n/a2/15/18143/1072/15/18100

CV007811/03/39CVUHB78Male2/5/18No2/5/18Yes2/5/18Yes132.02/5/18No2/5/18No2/5/18NoN/A2/5/18NoNoPrimaryNSCLC- Squamous Cell Cancer310Yes2/15/1810341202/15/180011402/15/1800112060806015/02/1862.52/15/181.738.62/15/188.615/02/18212/15/1819.32/15/1812/15/1826.52/15/1824.62/15/18302/15/1850.00002/15/18380n/an/a2/15/186%2/15/1822/15/182.26/2.99n/a2/15/18125/862/15/18952/15/18AusTOMS Scale 14444

CV007925/11/51CVUHB67Male2/12/18No2/12/18Yes2/12/18Yes138.02/12/18Yes2/12/18Yes2/12/18NoN/AYesPrimaryNSCLC- Squamous Cell Cancer430Yes2/15/180011402/15/180011302/15/1800112030806015/02/1877.92/15/181.685.62/15/185.615/02/1827.62/15/1827.92/15/1812/15/1829.52/15/1826.52/15/1826.62/15/1855.80002/15/18180n/an/a2/15/182%2/15/1822/15/182.26/2.74n/a2/15/18150/1072/15/18812/15/18AusTOMS Scale 23333AusTOMS Scale 43333

CV008031/07/42CVUHB75Male2/12/18No2/12/18Yes2/12/18No122.02/12/18No2/12/18Yes2/12/18NoN/AYesPrimaryMesotheliomaYes2/12/180011302/12/180011502/12/1801112060806012/02/1881.62/12/181.831.212/12/181.2112/02/1824.42/12/1827.32/12/1802/12/1827.52/12/18252/12/1826.32/12/1859.00002/12/18PT unable to undertake 6 minute walk test - PT in wheel chair and had balance problemsn/an/an/a2/12/184n/an/an/an/a2/12/18AusTOMS Scale 222222AusTOMS Scale 433333AusTOMS Scale 733333


CV008231/07/47CVUHBMaleNo00000000000000003030


CV008408/06/50CVUHB67FemaleYes00Yes2/15/1800441402/15/180002402/15/18001120120806015/02/1872.373.41.12/15/181.6502/15/18015/02/1826.627.00.42/15/1837.23/22/1836.9-0.32/15/1803/22/18002/15/1832.53/22/1831.5-12/15/1825.33/22/1824-1.32/15/1826.23/22/1821.6-4.62/15/1845.10003/22/1846.00000.90002/15/184303/22/18480502/15/181%3/22/181%0%2/15/1813/22/18102/15/181.76/2.213/22/181.53/3.27n/a2/15/18141/1013/22/18126/792/15/18803/22/1871-92/15/18AusTOMS Scale 14444

CV008528/06/39CVUHBMaleNo0000000000000003030

CV008618/05/53CVUHB64Female2/12/18No2/12/18Yes2/12/18NoYesPrimaryNSCLC- Squamous Cell Cancer420Yes2/19/180011602/19/181012502/19/1800112060806019/02/1862.82/19/181.67642/19/18419/02/1822.42/19/1838.12/19/1802/19/1827.52/19/1823.62/19/1819.12/19/1838.60002/19/18390n/an/a2/19/185%2/19/1812/19/181.27/2.50n/a2/19/18137/862/19/1887

CV008704/04/73CVUHB44Female2/2/18No2/2/18Yes2/2/18No89.02/2/18No2/2/18Yes2/2/18NoN/A2/2/18NoYesPrimaryNSCLC- Adenocarcinoma3003/7/18Yes2/22/180011702/22/180011202/22/1800112040303022/02/1853.52/22/181.6202/22/18022/02/1820.42/22/1827.32/22/1802/22/1825.52/22/1821.12/22/1824.42/22/1838.60002/22/18370n/an/a2/22/185%2/22/1812/22/182.44/3.45n/a2/22/18104/852/22/18842/22/18AusTOMS Scale 13444AusTOMS Scale 104444

CV008828/07/65CVUHB52Male1/9/18Yes1/9/18Yes1/9/18Yes147.01/9/18YesYesSecondaryYes2/22/180011302/22/182013602/22/1800116030806022/02/1865.12/22/181.733.72/22/183.722/02/1821.62/22/1820.22/22/1802/22/1826.52/22/1821.82/2/187.22/22/1851.60002/22/18PT to unwell to undertake walk testn/an/an/a2/22/1822/12/183.27/4.04n/an/an/a2/22/18AusTOMS Scale 23323AusTOMS Scale 43333

CV008910/06/40CVUHB77Male3/5/18No3/5/18Yes3/5/18Yes147.03/5/18Yes3/5/18Yes3/5/18NoN/AYesPrimaryNSCLC- Adenocarcinoma1b003/23/18Yes2/22/1810341302/22/180022502/22/1800000100806022/02/1890.491.10.72/22/181.7502/22/18022/02/1829.529.70.22/22/1833.23/12/1833.1-0.12/22/1803/12/18002/22/1829.53/12/18322.52/22/18273/12/1829.52.52/22/1829.63/12/1828.7-0.92/22/1860.10003/12/1860.60000.50002/22/183403/12/18360202/22/1820%3/12/189%-11%2/22/1823/12/18202/22/182.64/3.403/12/182.69/3.42n/a2/22/18190/963/12/18182/1072/22/18653/12/188116

CV0090MaleN/ANo00000000000000003030

CV009116/04/41CVUHB77Male2/5/18No2/5/18No2/5/18Yes152.02/5/18Yes2/5/18Yes2/5/18NoN/AYesPrimaryYes2/15/180011202/15/181012302/15/1800112040806015/02/1858.82/15/181.728.82/15/1828.815/02/1820.42/15/18272/15/1832/15/1822.52/15/1820.52/15/1819.42/15/1842.60002/15/18PT not able to undertake 6 minute walk test - Frail gentleman attedned in wheel chair. Significant functional issues. Only capable of supervised assisted transfers and very short mobilityn/an/an/a2/15/184N/AN/A2/15/1899/562/15/18972/15/18AusTOMS Scale 233333AusTOMS Scale 433333AusTOMS Scale 733333

CV0092N/ANo0000000000000003030

CV009308/05/43CVUHB74Male2/19/18No2/19/18Yes2/19/18Yes153.02/19/18Yes2/19/18Yes2/19/18NoN/A2/19/18NoYesPrimaryYes2/26/180011802/26/18000002/26/1800112060806026/02/1872.22/26/181.702/26/18026/02/18252/26/18252/26/1802/26/18242/26/1821.22/26/1835.52/26/1853.80002/26/18360n/an/a2/26/1819%2/26/1822/26/182.05/3.52n/a2/26/18150/922/26/18642/26/18AusTOMS Scale 244344


CV009519/01/42CVUHB76Female2/1/18No2/1/18No2/1/18Yes136.02/1/18No2/1/18Yes2/1/18NoN/A2/1/18YesYesPrimary1c00Yes3/1/180001603/1/180001403/1/180000040806001/03/1847.53/1/181.493.13/1/183.101/03/18233/1/1831.43/1/1803/1/18243/1/1819.63/1/18153/1/1832.30003/1/18300n/an/a3/1/180%3/1/1823/1/181.39/2.35n/a3/1/18112/713/1/1870

CV009603/05/18CVUHB72Male2/16/18No2/16/18Yes2/16/18Yes156.02/16/18YesN/A2/16/18YesYesPrimary1c00Yes3/5/180011303/5/180001303/5/1800112050806005/03/1893.83/5/181.7503/5/18005/03/1830.63/5/1833.63/5/1803/5/1833.53/5/1828.53/5/1831.53/5/1862.00003/5/18PT too unwell to undertake 6 minute walk testn/an/a3/5/186%3/5/184N/AN/A3/5/18128/923/5/18753/5/18AusTOMS Scale 22233

Male

Female

Did not wish to disclose

7/30/19

Prince Phillip

Withybush

Morriston

Singleton

NPTH

POWH

UHL

Nevill Hall

St Woolos

Velindre

Yes

No

N/A

Yes

No

Already Known

N/A

30 Day

90 Day

N/A

COPD

Asthma

Pulmonary Fibrosis

Other

First line advice and support

Dietetics

NERS

Physiotherapy

Occupational Therapy

Counselling

Other

Lobectomy

Pneumonectomy

Wedge Resection

Segmentectomy

VATS Procedure

Radiotherapy

SABR

CHART

Sequential

Adjuvant

Palliative

Neo-Adjuvant

Open

Laparoscopic

Other

AusTOMS Scale 1

AusTOMS Scale 2

AusTOMS Scale 3

AusTOMS Scale 4

AusTOMS Scale 5

AusTOMS Scale 6

AusTOMS Scale 7

AusTOMS Scale 8

AusTOMS Scale 9

AusTOMS Scale 10

AusTOMS Scale 11

AusTOMS Scale 12

At least 150 minutes of moderate- intensity aerobic physical activity a week

At least 75 minutes of vigorous-intensity aerobic physical activity a week

An equivalent combination of both the above

Physical activity but not to the levels stated above

No physical activity

Primary

Secondary

SCLC

NSCLC- Adenocarcinoma

NSCLC- Squamous Cell Cancer

NSCLC- Large Cell Carcinoma

NSCLC- Undifferentiated

Mesothelioma

Pancoast

Yes- Completed

No- Declined

N/A- Not Offered

v7

v8

ABMUHB

CVUHB

ABUHB

For men: LBM = (0.32810 x W) + (0.33929 x H) - 29.5336For women: LBM = (0.29569 x W) + (0.41813 x H) - 43.2933

Lean Body Mass (hyperlink)

Prehab only

Final StagingOT AssessmentPre-TreatmentPost-Treatment

Patient CodeDOB (dd/mm/yy)AgeSexMalignant diseasePrimary siteDiagnosis of Lung Cancer made?Primary or Secondary CancerIf a diagnosis of lung cancer is made please note the type belowTNMTreatmentDid the patient attend prehabilitation?Weight Dietetic Assessment (weight in kg)Weight Pre-Treatment 1 (weight in kg)Weight Overall ChangeBaseline Height (metres)Percentage weight loss in last 6 months(% wt loss) Dietetic Assessment% WT loss Overall Change(BMI) Dietetic Assessment(BMI) Pre-Treatment 1BMI Overall Change(%body fat) Dietetic Assessment(%body fat) Pre-Treatment 1% Body Fat Overall Change(MUST) Dietetic Assessment(MUST) Pre-Treatment 1MUST Overall Change(MUAC) Dietetic Assessment (cm)(MUAC) Pre-Treatment 1 (cm)MUAC Overall Change(MUMC) Dietetic Assessment (cm)(MUMC) Pre-Treatment 1 (cm)MUMC Overall Change(HG) Dietetic Assessment (mmHg)(HG) Pre-Treatment 1 (mmHg)HG Overall Change(LEAN BM) Dietetic Assessment(LEAN BM) Pre-Treatment 1Lean BM Overall Change6MWT Physio Assessment (metres)6MWT Pre-Treatment 1 (metres)6MWT Overall Change (metres)Level of desaturation Physio AssessmentLevel of desaturation Pre-Treatment 1Level of desaturation Overall ChangeMRC Physio AssessmentMRC Pre-Treatment 1MRC Overall ChangeFEV1/FVCPhysio AssessmentFEV1/FVC Pre-Treatment 1FEV1/FVC Overall ChangeFEF 25%-75% Physio AssessmentFEF 25%-75% Pre-Treatment 1FEF 25%-75% Overall ChangeBP Physio AssessmentBP Pre-Treatment 1BP Overall ChangeHR Physio AssessmentHR Pre-Treatment 1HR Overall ChangeDate (dd/mm/yy)ScaleImpairmentActivity LimitationParticipation RestrictionDistress ClientDistress CarerScale2Impairment3Activity Limitation4Participation Restriction5Distress Client6Distress Carer7Scale8Impairment9Activity Limitation10Participation Restriction11Distress Client12Distress Carer13Date (dd/mm/yy)14Scale15Impairment16Activity Limitation17Participation Restriction18Distress Client19Distress Carer20Scale21Impairment22Activity Limitation23Participation Restriction24Distress Client25Distress Carer26Scale27Impairment28Activity Limitation29Participation Restriction30Distress Client31Distress Carer32Date (dd/mm/yy)33Scale34Impairment35Activity Limitation36Participation Restriction37Distress Client38Distress Carer39Scale40Impairment41Activity Limitation42Participation Restriction43Distress Client44Distress Carer45Scale46Impairment47Activity Limitation48Participation Restriction49Distress Client50Distress Carer51Discharge CodeFatigue (FACIT-F) Baseline AssessmentFatigue (FACIT-F) Pre-Treatment 1Fatigue (FACIT-F) Overall ChangeEQ5D5L QOL Baseline AssessmentEQ5D5L QOL Pre-Treatment 1EQ5D5L QOL Overall ChangeEQ5D5L Mobility Score Baseline AssessmentEQ5D5L Mobility Score Pre-Treatment 1EQ5D5L Mobility Score Overall ChangeEQ5D5L Self Care Score Baseline AssessmentEQ5D5L Self Care Score Pre-Treatment 1EQ5D5L Self Care Score Overall ChangeEQ5D5L Usual Activities Score Baseline AssessmentEQ5D5L Usual Activities Score Pre-Treatment 1EQ5D5L Usual Activities Score Overall ChangeEQ5D5L Pain/Discomfort Score Baseline AssessmentEQ5D5L Pain/Discomfort Score Pre-Treatment 1EQ5D5L Pain/Discomfort Score Overall ChangeEQ5D5L Anxiety/Depression Score Baseline AssessmentEQ5D5L Anxiety/Depression Score Pre-Treatment 1EQ5D5L Anxiety/Depression Score Overall ChangePerformance Status Baseline AssessmentPerformance Status Pre-Treatment 1Performance Status Overall ChangeFrailty Index Baseline AssessmentFrailty Index Pre-Treatment 1Frailty Index Overall ChangeDate of pre-operative assessment clinic (dd/mm/yy)Date of admission to surgical ward (dd/mm/yy)Ward Name/ NumberIs this the appropriate ward for the specialityActual date of surgery (dd/mm/yy)Critical Care PlannedTotal length of stay in critical care (hrs)Total length of stay in hospital (days)Did the patient follow the ERAS Pathway?Did the patient require antibiotics during their stay (other than the Prophylactic dose)IndicationDid the patient require a blood transfusion?

CV000130/12/3482MaleNoN/ANoNot cancerYes65.2682.81.7029.69.622.523.51.020.720.1-0.610-128.528.5017.817.7-0.118.818-0.851.100053.90002.800048649042%3%1%1101.67/3.13n/a150/81145/75626429/21/17AusTOMS Scale 254545149-260n/a02211011011011000032-1

CV000324/09/4671MaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer2a20Palliative ChemotherapyYes89.61.773.73.728.629.503528.634.959.70003203%3N/AN/A170/83839/18/17AusTOMS Scale 2444530n/a80n/a2n/a1n/a2n/a1n/a2n/a14

CV000428/01/3879FemaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer301bPalliative ChemotherapyYes56.457.61.21.6519920.721.10.431.131-0.110-1202331117.96.916.4170.638.400039.50001.1000unable to untake walktest due to being too unwellN/AN/A3302.01/3.130.28 - 3.69N/AN/AN/AN/A9/21/17AusTOMS Scale 8223210/12/17AusTOMS Scale 833321316360802031-221-132-131-241-3220440

CV000628/04/5067MaleYesLungYesPrimaryNSCLC- Adenocarcinoma2a21bRadical RadiotherapyYes8583-21.6513.43.431.230.4-0.834.635.10.50003045.733.155.200053.8000-1.4000N/ANot able to do test due to spinae bifidaN/A2N/AN/AN/AN/A9/21/17AusTOMS Scale 2333340.121-19.1300-30440330440440231220440

CV000708/03/4770FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma2a00SurgeryYes62.562.60.11.672222.422.40.03539.24.200025.524.5-122.0520.42-1.631012.52.540.200037.8000-2.400041701660%2%2%52-31.59/2.671.57/2.85N/A0.17-2.13N/A123/84N/A759/25/17AusTOMS Scale 423233AusTOMS Scale 733233AusTOMS Scale 122223311/6/17AusTOMS Scale 433343AusTOMS Scale 732343AusTOMS Scale 12222339.75188.2530653543-144044011043-132-165-111/2/1711/20/17C5Yes11/21/17Yes4824NoNoNo

CV000806/01/5760MaleNoN/ANoNot cancerYes751.78UnknownUnknown23.7191292729.760.40003803%13.59/4.970.87 - 6.92171/107979/28/17AusTOMS Scale 14444n/an/an/an/an/an/an/an/an/an/an/an/an/an/a01

CV001012/09/5661MaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer3X0SurgeryYes8383.40.41.727UnknownUnknown27.828.00.2N/A0N/AN/AN/AN/A570590205%3%-2%1102.22/3.382.10/3.270.35 - 4.17164/93155/878375-810/5/17AusTOMS Scale 43344374038080011011011022022000022012/18/1712/28/17C5Yes12/29/17No5NoNo

CV001118/02/3582MaleYesLungYesPrimary431bBest Supportive CareYes941.67unknownunknown33.738.302824.918.557.7000N/AN/A5N/AN/AN/AN/A10/9/17AusTOMS Scale 21113AusTOMS Scale 51113AusTOMS Scale 71113N/An/aN/An/aN/An/aN/An/aN/An/aN/An/aN/An/a36

CV001211/02/6057FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma331bPalliative ChemotherapyYes70.270-0.21.61unknownunknown2727.00.0N/A000N/AN/AN/AN/ANo 6 walk test due to dizzinessN/A1N/AN/AN/AN/A10/5/17AusTOMS Scale 133343320-13N/An/a12112123122012102

CV001316/01/4077MaleYesLungYesPrimaryNSCLC- Adenocarcinoma2a00SurgeryYes84.883-1.81.77UnknownUnknown2726.5-0.5N/A0N/AN/AN/AN/A230220-10Plus 4%Plus 4%0%21-12.03 /3.761.98/3.560.15-2.57136/73145/70696904341-27070033011023123122011055012/4/1712/18/17C5Yes12/19/17Yes244NoNoNo

CV001501/10/5067MaleNoN/ANoNot cancerYes1011.77unknownunknown32.20N/AN/AN/AN/A3502%03.48/4.52n/a156/6868n/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a

CV001630/10/4373FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma1a00SurgeryYes681.620026.338.80292321.542.2000410420103%5%2%1100.86/1.80.18-0.77142/75138/78778912n/an/an/an/an/an/an/an/an/an/an/an/an/an/a1n/a10/31/1711/7/17C5Yes11/8/17Yes248NoNoNo

CV001716/10/4175MaleYesLungYesPrimaryNSCLC- Adenocarcinoma221bActive monitoringYes81.41.798.58.525.428.5131.527.732.557.8000N/AN/A0n/an/aN/AN/A11/2/17AusTOMS Scale 543342n/a100n/a4n/a4n/a4n/a4n/a4n/a36

CV001808/06/4671FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma2a30Radical RadiotherapyYes57.6580.41.520024.925.10.230.329.6-0.70002726-123.221.3-1.920.119.4-0.739.800040.50000.7000340370309%1%-8%1101.02/1.940.88/1.82n/a0.93-0.89115/71130/6882897323319090033011033043-1231110330

CV001919/10/4674FemaleYesLungYesPrimary1b00Radical RadiotherapyYes62.463.20.81.620023.924.10.236.336.300003131026.926.9019.522.42.939.500040.00000.50001401602014%2%-12%32-10.87/2.520.91/2.400.10-0.570.24119/74130/788577-842.541.2-1.370902033021-133044021-1220550

CV002019/09/2687MaleYesLungYesPrimaryNSCLC- Adenocarcinoma300Palliative ImmunotherapyYes751.719.19.125.634.212724.228.649.4000215Plus 12%2N/AN/A117/66726n/a75n/a4n/a2n/a4n/a4n/a3n/a25

CV002108/12/5561MaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer1a00SurgeryYes65.667.82.21.7020022.623.40.817.316.4-0.90002727.50.524.525.20.735.532.1-3.453.800056.20002.4000500550505%1%-4%1103.3/4.80.47- 6.88121/80121/887678248n/a90n/a1n/a1n/a1n/a1n/a1n/a0211/7/1711/10/17C5Yes11/13/17No04NoNoNo

CV002317/11/6254FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma2a30Palliative ChemotherapyYes59.263.84.61.6263.13.122.424.11.733.335.92.600025.524-1.519.516.83-2.679.918.9939.200040.60001.40003505401903%6%3%220N/AN/A142/81156/818391811/2/17AusTOMS Scale 244442024420503033013223133043-1110440

CV002423/08/4770FemaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer1a00SurgeryYes901.60034.946.103225.123.848.1000350330-205%2%-3%1102.03/3.000.31-3.89135/748286443n/a70n/a3n/a1n/a2n/a3n/a2n/a1411/21/1711/27/17C5Yes11/28/17Yes244NoNoNo

CV002525/04/4869MaleNoN/ANoSurgeryYes6870.22.21.7025523.424.20.819.720.10.40002930125.9282.141.143.72.654.100055.80001.7000550570201%1%0%1103.16/4.623.11/4.560.48-7.98132/85171/9856731710/30/17AusTOMS Scale 1344351521100100011011011022042-200011012/11/1712/21/17C5Yes12/22/17No05NoNoNo

CV002623/01/4275FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma2b00Palliative RadiotherapyYes39.640.40.81.6282815.515.80.327.128.31.24402121.50.518.218.360.1614.214.80.628.200028.70000.500009090N/A032-10.93/2.330.16-0.85N/A103/68N/A1101324116040-2042-211043-142-223133065-1

CV002812/12/3779FemaleYesLungYesPrimary1b00Active monitoringYes39.640.81.21.4715.315.318.318.90.629.530.61.142-220.520.5017.0518.261.2115.414.9-0.527.600028.00000.4000290350601%1%0%3300.93/1.820.12-0.96138/72127/666664-211/2/17AusTOMS Scale 23333N/A2538136560-533011031-2220121220440

CV002922/02/6057MaleYesLungYesPrimaryNSCLC- Adenocarcinoma2a00SurgeryYes58.260.221.727.67.619.720.30.615.915.8-0.121-12525022.522.60.14542-348.400050.20001.8000460410-504%1%-3%1102.71-4.022.66-4.080.49-4.940.34-4.83124/85105/7267851811/2/17AusTOMS Scale 10122223037770801011011021-111043-100022011/22/1711/27/17C5Yes11/28/17No06NoNoNo

CV003017/06/4671MaleYesLungYesSecondarySurgery (Skin)Yes83.21.830024.824.6029.525.736.762.40004907%1N/AN/A163/837011/2/17AusTOMS Scale 43344342n/a95n/a1n/a1n/a1n/a1n/a1n/a01

CV003109/07/4176FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma2b10Surgery (open/close)Yes551.62613.413.420.837.322523.310.634.20003804%32.06/3.080.25-5.17109/637311/6/17AusTOMS Scale 10112219n/a90n/a2n/a1n/a3n/a3n/a1n/a1421

CV003201/06/5067FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma1a10SurgeryYes65.465.2-0.21.570026.526.5-0.035.134.9-0.200026.5270.524.925.70.820.322.72.442.100042.20000.1000420440204%3%-1%1101.63/3.250.30-1.74131/83152/927486125445-99090011011011011011011044012/5/1712/19/17C5Yes12/20/17No7NoNoNo

CV003322/06/4473FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma2a00Active monitoringYes651.524.44.428.143.402523.417.536.5000N/AN/A30.67/1.510.13-0.55N/AN/AN/An/aN/An/a2n/a1n/a3n/a3n/a2n/a36

CV003424/04/4770FemaleNoN/ANoNot cancerYes471.60018.327.3224.522.718.933.800016002N/AN/A103/655312n/a75n/a4n/a3n/a4n/a3n/a3n/a23

CV003605/09/6552FemaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer420Palliative ChemotherapyYes45.81.54920201924.332421.816.234.40003704%21.86/2.831.19152/819911/23/18AusTOMS Scale 43332n/an/an/an/an/an/an/an/an/an/an/an/an/an/a0n/a

CV003712/02/6354FemaleNoN/ANoNot cancerYes38.21.66323213.916.5420.518.4610.831.5000Declined testdeclined test21.3/2.80.31-1.31declined testdeclined test11/27/17AusTOMS Scale 2223344n/a90n/a2n/a1n/a2n/a1n/a1n/a2n/a

CV003812/11/4968FemaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer431bPalliative ChemotherapyYes78.61.65112.712.728.843.223229.412.144.40001303%3N/AN/A115/7511810n/a80n/a4n/a3n/a4n/a4n/a3n/a37

CV004016/08/5166FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma1a00SurgeryYes64.864.1-0.71.5720026.225.9-0.34036-400035.529-6.529.522.7-6.826.424-2.438.600040.70002.1000260310503%5%2%2201.44/2.511.36/2.240.15-1.91140/78132/745793365152110070-302201101101101101104402/22/183/12/18C5Yes3/14/18Yes246NoNoNo

CV004129/07/3780MaleYesLungYesPrimaryNSCLC- Adenocarcinoma2a01bPalliative ChemotherapyYes75.81.7782.82.82425.702926.427.555.90003303%2N/AN/A155/856211n/a45n/a3n/a3n/a5n/a3n/a3n/a26

CV004305/02/6948FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma1b00SurgeryYes112.6112.601.6760040.140.1-0.050.249.9-0.30004241.5-0.533.232-1.227.526.9-0.655.900056.20000.3000430460303%2%-1%110N/A2.22/2.61N/A0.99-7.56150/80137/797368-53848108598131101101101102200002202/21/183/12/18C5Yes3/13/18No04NoNoNo

CV004405/04/5166FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma2a00SurgeryYes81.283.11.91.5003636.90.94949.50.50003736-13630.4-5.612.913.70.841.200042.00000.8000310360500%3%3%21-12.08/2.731.99/2.100.40-5.29150/89136/86767603939050904032-11102203302311102201/10/181/22/18C5Yes1/23/18244.5NoNoNo

CV004624/08/6651FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma400Radical Chemotherapy and RadiotherapyYes5855.6-2.41.613322.421.4-1.031.629.6-200028.527.5-126.625.9-0.720.523.42.939.400038.9000-0.5000360Not possible due to be too unwell5%2N/AN/A117/8982/64791355624n/a50n/a1n/a1n/a1n/a2n/a2n/a04

CV004722/09/4869FemaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer1b21bPalliative ChemotherapyYes43.61.586.86.817.533.631815.31128.6000Not possible on home visitn/a20.92/1.810.27-0.96108/67981/11/18AusTOMS Scale 233333AusTOMS Scale 433333AusTOMS Scale 82222242n/a80n/a2n/a1n/a1n/a1n/a1n/a25

CV004827/12/4473MaleNoN/ANoNot cancerYes45.21.727212115.29.142017.3132.840.60003801%12.17/3.360.66-3.27132/787550n/a90n/a1n/a1n/a1n/a1n/a1n/a13

CV005004/09/5661MaleYesLungYesPrimaryNSCLC- Adenocarcinoma431bRadical RadiotherapyYes80.41.6760028.627.9027.525.1634.857.7000450Not possible due to treatment starting urgently11%11.56/2.50n/a145/87741/11/18AusTOMS Scale 44444440n/a60n/a1n/a1n/a2n/a3n/a1n/a03

CV005130/03/4869FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma421bPalliative RadiotherapyYes76.772.9-3.81.659.29.22826.8-1.243.442.1-1.312127.5302.523.4251.621.124.23.143.400041.9000-1.5000420PT unable due to feeling nausea and vomiting4%11.58/2.28n/a135/81841/11/18AusTOMS Scale 4444443/5/18AusTOMS Scale 3333343.3n/a80n/a1n/a1n/a1n/a2n/a1n/a11043-1

CV005216/05/6057FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma421aPalliative ChemotherapyYes5657.31.31.6unknownunknown2222.40.432.332.90.600025.5260.521.120.7-0.420.622.82.237.600038.00000.4000500490-106%3%-3%2201.30/2.11.53/2.660.72122/67124/73727751/11/18AusTOMS Scale 1333348.7547-1.759070-2011011051-411043-1110330

CV005307/06/4077MaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer320Best Supportive CareYes53.41.72730unknown17.9unable due to pacemaker42421.621.6unable due to pacemakerNot possible due to home visitn/a32.2/2.51.33-4.82112/63761/11/18AusTOMS Scale 2323335n/a25n/a4n/a4n/a5n/a4n/a3n/a15

CV005412/05/3678MaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer2a30Palliative ChemotherapyYes83.884.91.11.790026.226.50.326.226.1-0.10002929026.326.80.532.132-0.161.800062.40000.60004404804012%7%-5%1102.51/3.390.53-6.91156/78135/926478144640-660802031-221-121-1330110110330

CV005531/12/5562FemaleYesThymusNoPrimarySurgery (Thymic Ca)Yes44.443.8-0.61.6531.131.116.316.1-0.221.620.1-1.544021.521.501918.4-0.615.616.10.534.400034.60000.200030042012014%3%-11%220N/A1.78/2.12N/A94/5882/578687120n/a45n/a3n/a2n/a3n/a4n/a2n/a11054-12/14/182/22/18C5Yes2/23/18Yes11514NoNoNo

CV005601/07/5859FemaleYesLung CarcinoidNoPrimarySurgery (Carcinoid)Yes75.474.1-1.31.6260028.528.0-0.535.232.4-2.80003333.50.526.125-1.127.627.5-0.148.500049.80001.3000470520501%2%1%1102.74/3.622.61/3.11n/a165/79177/75828314543-2707001101101101101100001102/14/183/11/18C5Yes3/12/18No03NoNoNo

CV005703/02/5265MaleYesLungYesPrimaryNSCLC- Adenocarcinoma411aPalliative ChemotherapyYes67.61.7126.326.323.124.9227.524.428.450.40003807%21.90/2.39n/a127/82983626-106080201101102202312311220

CV005825/09/4473FemaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer420Best Supportive CareYes441.476.46.420.434.4124.520.413.628.50002803%21.31/1/661.18112/648824n/a70n/a1n/a1n/a2n/a3n/a2n/a24

CV005907/05/4077MaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer421aPalliative ChemotherapyYes921.7780029.129.7031.529.633.564.4000PT able to complete test due to balance problemsN/A12.02/3.530.25-2.70180/94630n/a20n/a4n/a4n/a5n/a4n/a4n/a13

CV006013/01/5563MaleYesLungYesPrimary421aPalliative ChemotherapyYes64.81.85414.714.718.916.6327.526.233.753.70004903%21.77/2.09n/a115/818135n/a50n/a1n/a1n/a1n/a2n/a2n/a13

CV006119/04/5166MaleNoN/ANoNot cancerYes901.76intentional weight lossintentional weight loss29not undertaken due to irregular heart bet030.526.4230.6Not untaken due to irregular heart beat4902%11.94/2.22n/a171/826050n/a80n/a1n/a1n/a1n/a1n/a1n/a13

CV006414/02/5364FemaleNoN/ANoNot cancerYes651.6260024.633.20N/AN/AN/A43.100045015%2N/AN/A145/789848n/a90n/a1n/a1n/a1n/a1n/a2n/a12

CV006603/05/6057MaleYesLungYesPrimaryMesotheliomaX00Palliative ChemotherapyYes62.260.1-2.11.70021.520.8-0.715.215.80.600027.525.5-225.323.6-1.743.843-0.852.300050.2000-2.10004405401003%14%11%110n/an/a135/70140/726865-32/22/18AusTOMS Scale 2333334444070801011011032-1220220000220

CV007011/10/6057FemaleNoN/ANoSurgery (not Cancer)Yes74.61.549.69.631.542.9132.524.924.342.40004303%20.97/2.61n/a118/8276N/A41N/A60N/A2N/A1N/A2n/a2N/A22203302/8/183/5/18C5Yes3/6/18Yes2421NoYesChest sepsis (smoking up to day of operationNo

CV007118/05/6453FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma300SurgeryYes941.7UnknownUnknown35.5241035.528055.20004305%12.79/3.26n/a108/787423n/a60n/a3n/a1n/a3n/a3n/a3n/a022/14/182/26/18C5Yes2/27/18Yes05NoNoNo

CV007214/04/4968MaleNoN/ANoNot cancerYes102.41.7650032.930.7034.530.435.370.60004406%13.16/4.34n/a168/947934n/a80n/a1n/a1n/a1n/a2n/a3n/a01

CV007309/10/4473FemaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer300SurgeryYes64.61.679.19.123.233.21252223.842.8000400420203%1%-2%1101.83/2.811.81/2.28n/a158/7567952839n/a90n/a1n/a1n/a1n/a2n/a4n/a022/19/182/25/18C5Yes2/26/18No06NoNoNo

CV007405/10/6354FemaleNoN/ANoNot cancerYes79.21.63unknownunknown29.836.2133.528.322.950.20004205%11.71/2.26n/a125/907924n/a80n/a1n/a1n/a2n/a2n/a2n/a02

CV007720/07/4572FemaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer421bPalliative ChemotherapyYes79.11.57003247.7035.528.914.141.100015015%31.11/1.20n/a143/10710021n/a80n/a3n/a2n/a3n/a3n/a1n/a14

CV007811/03/3978MaleNoN/ANoNot cancerYes62.51.738.68.62119.3126.524.63050.00003806%22.26/2.99n/a125/86952/15/18AusTOMS Scale 1444448n/a90n/a1n/a1n/a1n/a2n/a1n/a02

CV007925/11/5167MaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer430Palliative ChemotherapyYes77.91.685.65.627.627.9129.526.526.655.80001802%22.26/2.74n/a150/107812/15/18AusTOMS Scale 23333AusTOMS Scale 4333310n/a70n/a3n/a3n/a3n/a3n/a3n/a24

CV008031/07/4275MaleYesLungYesPrimaryMesotheliomaBest Supportive CareYes81.61.831.211.2124.427.3027.52526.359.0000PT unable to undertake 6 minute walk test - PT in wheel chair and had balance problemsn/a4n/an/an/an/a2/12/18AusTOMS Scale 222222AusTOMS Scale 433333AusTOMS Scale 73333315n/a30n/a3n/a3n/a5n/a3n/a3n/a24

CV008408/06/5067FemaleNoN/ANoSurgery (not cancer)Yes72.373.41.11.650026.627.00.437.236.9-0.300032.531.5-125.324-1.326.221.6-4.645.100046.00000.9000430480501%1%0%1101.76/2.211.53/3.27n/a141/101126/798071-92/15/18AusTOMS Scale 14444495019095511011011011031-200021-13

CV008618/05/5364FemaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer420Radical Chemotherapy and RadiotherapyYes62.81.6764422.438.1027.523.619.138.60003905%11.27/2.50n/a137/868745n/a95n/a1n/a1n/a1n/a1n/a1n/a01

CV008704/04/7344FemaleYesLungYesPrimaryNSCLC- Adenocarcinoma300SurgeryYes53.51.620020.427.3025.521.124.438.60003705%12.44/3.45n/a104/85842/22/18AusTOMS Scale 13444AusTOMS Scale 10444439n/a84n/a1n/a1n/a2n/a4n/a2n/a022/28/183/6/18C5Yes3/7/18No02NoNoNo

CV008828/07/6552MaleYesLungYesSecondary4a2b0Palliative Chemotherapy (Larynx)Yes65.11.733.73.721.620.2026.521.87.251.6000PT to unwell to undertake walk test23.27/4.04n/an/an/a2/22/18AusTOMS Scale 23323AusTOMS Scale 43333n/an/an/an/an/an/an/an/an/an/an/an/an/an/a15

CV008910/06/4077MaleYesLungYesPrimaryNSCLC- Squamous Cell Cancer1c00SurgeryYes90.491.10.71.750029.529.70.233.233.1-0.100029.5322.52729.52.529.628.7-0.960.100060.60000.50003403602020%9%-11%2202.64/3.402.69/3.42n/a190/96182/1076581165049-110090-101211101211101101102203/20/18C5Yes3/23/18Yes7NoNoNo

CV009116/04/4177MaleYesLungYesPrimaryBest Supportive CareYes58.81.728.828.820.427322.520.519.442.6000PT not able to undertake 6 minute walk test - Frail gentleman attedned in wheel chair. Significant functional issues. Only capable of supervised assisted transfers and very short mobilityn/a4N/AN/A99/56972/15/18AusTOMS Scale 233333AusTOMS Scale 433333AusTOMS Scale 7333335n/a35N/A3n/a3n/a5n/a5n/a5n/a36

CV009308/05/4374MaleYesLungYesPrimary1b00Active monitoringYes72.21.700252502421.235.553.800036019%22.05/3.52n/a150/92642/26/18AusTOMS Scale 24434452n/a90n/a1n/a1n/a2n/a1n/a1n/a03

CV009519/01/4276FemaleYesLungYesPrimary1c00SurgeryYes47.51.493.13.12331.402419.61532.30003000%21.39/2.35n/a112/717022n/a69n/a3n/a1n/a3n/a3n/a3n/a257

CV009603/05/1872MaleYesLungYesPrimary1c00Active monitoringYes93.81.750030.633.6033.528.531.562.0000PT too unwell to undertake 6 minute walk test6%4N/AN/A128/92753/5/18AusTOMS Scale 2223317n/a60N/A4n/a2n/a4n/a3n/a4n/a33

Demographics

Row LabelsCount of SexCount of Sex2

Female3752.9%

Male3347.1%

Grand Total70100.0%

Average of AgeMin of AgeMax of Age

67.644.087.0

Row LabelsCount of Malignant diseaseCount of Malignant disease2

No1420.0%

Yes5680.0%

Grand Total70100.0%

Row LabelsCount of Primary siteCount of Primary site2

Lung5477.1%

Lung Carcinoid11.4%

N/A1420.0%

Thymus11.4%

Grand Total70100.0%

Row LabelsCount of Diagnosis of Lung Cancer made?Count of Diagnosis of Lung Cancer made?2

No1622.9%

Yes5477.1%

Grand Total70100.0%

Row LabelsCount of TCount of T2

212.0%

3815.7%

41427.5%

1a59.8%

1b59.8%

1c35.9%

2a1121.6%

2b23.9%

4a12.0%

X12.0%

(blank)0.0%

Grand Total51100.0%

Row LabelsCount of TreatmentCount of Treatment 2

Active monitoring57.1%

Best Supportive Care57.1%

Not cancer1115.7%

Palliative Chemotherapy1622.9%

Palliative Chemotherapy (Larynx)11.4%

Palliative Immunotherapy11.4%

Palliative Radiotherapy22.9%

Radical Chemotherapy and Radiotherapy22.9%

Radical Radiotherapy45.7%

Surgery1724.3%

Surgery (Carcinoid)11.4%

Surgery (not Cancer)22.9%

Surgery (open/close)11.4%

Surgery (Skin)11.4%

Surgery (Thymic Ca)11.4%

Grand Total70100.0%

Row LabelsCount of Did the patient attend prehabilitation?

Yes70

Grand Total70

Average of (BMI) Dietetic AssessmentMin of (BMI) Dietetic AssessmentMax of (BMI) Dietetic Assessment

25.013.940.1

Row LabelsCount of Current Smoker2

No63

Yes31

(blank)

Grand Total94

Sheet1

Sheet3

Sheet2

Patient CodeAgeSex(MUAC) Dietetic Assessment (cm)Centile(MUAC) Pre-Treatment 1 (cm)MUAC Overall Change(MUMC) Dietetic Assessment (cm)(MUMC) Pre-Treatment 1 (cm)MUMC Overall Change

CV000182Male28.528.5017.817.7-0.1

CV000371Male3528.6

CV008744Female25.55th21.1

CV000667Male3045.7

CV004348Female4290th41.5-0.533.232-1.2

CV000860Male2927

CV001061MaleN/AN/A

CV001182Male2824.9

CV004651Female28.515th27.5-126.625.9-0.7

CV001377MaleN/AN/A

CV001567MaleN/AN/A

CV003652Female24

Questions asked of thePrehabilitation (POP)participants?

All Health Board

Average Score(range of score 1 stronglydisagree – 4 stronglyagree)

I understood the purpose of POP 4

I understand what POP involved and what was expected of me 4

I think POP started at the right time 4

I think I had the right amount of time on the POP to help me 4

I felt supported through the POP 4

I felt supported by the POP and throughout 4

I felt the staff delivering prehabilitation were friendly 4

I felt I had the right amount of time to answer questions 4

I felt I received the right amount of emotional support 4

I felt the questions raised were answered so I could understand 4

I would recommend POP to others 3.9

Patient Experience

IMPACT and ENGAGEMENT

“

Lobbied for Inclusion in the Cancer Delivery Plan 2016-2020

Stakeholder Event

A Team Effort!

Enhanced Recovery Society UK Prehab survey Nov 2018

• Survey monkey• Closed and open ended questions• Voluntary• Circulated via networks and via ERAS UK

membership and websites• Open for 1 month

Results (1)Respondees 97 from Wales CNS 24 (25%)Consultant 35 (35%)Allied health professional 19 (20%)GP 3 (3%) Other staff 16 (17%)Offering prehab 39 (40%)Not offering/in planning 58 (60%)If offering – how long has it been used 27 responses

Results (2)

Prehab RCT Vs implementation

0 (0%) 27 (100%)

Who leads prehab in Welsh health boards

Anaesthetist 2 POW, AneurinBevan

CNS 2 CAV, Brecon

Allied health professional 7 CAV Breast, Wales Cancer Network, Lung

No idea 86

Which Modalities are routinely used?

Exercise 15 (58%)Nutrition 14 (54%)Psychology 13 (50%)Smoking cessation 17 (65%)Alcohol advice 8 (31%)Comorbidity advice 7 (27%)CPET 9 (35%)All modalities available and offered 5 (19%)

*All secondary care led and delivered

Barriers and Solutions to Prehab delivery

Barriers SolutionsLack of awareness Funding!Lack of leadership EducationFinances! National policyInsufficient staff and estates

Executive engagement

Waiting times Standards and guidelines

Macmillan Principles and Guidance

Page 27

Perfectly poised……????

Slide Number 1‘’Nutrition – the Skeleton in the Hospital Cupboard’’ Slide Number 3Slide Number 4Slide Number 5Slide Number 6Slide Number 7How do you change �Practice?��WHAT MAKES CHANGE HAPPEN?Slide Number 10All Wales ERAS CollaborativeBasic Principles of ERAS:Slide Number 13Length of Hospital Stay – All WalesFirst Step of all wales Enhanced Recovery:�prehab and primary care optimisation????�Slide Number 16Summary Results Feedback from Primary CareSlide Number 19Length of hospital stay in WalesSlide Number 21Slide Number 22Can prehabilitation make surgery a viable option for a newly diagnosed patient with cancer who is initially deemed to be too�high of a risk for surgical resection?��Gemma Thomas, Ira Goldsmith and colleagues Thoracic SurgeryPre-treatment Optimisation and Prehabilitation programme Slide Number 25Slide Number 26Background to POP ProgrammeLung Cancer Prehab Programme �CAV only OutcomesSlide Number 29Slide Number 30IMPACT and ENGAGEMENTSlide Number 32Stakeholder EventSlide Number 34A Team Effort!Enhanced Recovery Society UK Prehab survey Nov 2018Results (1)Results (2)Who leads prehab in Welsh health boards Which Modalities are routinely used?Barriers and Solutions to Prehab deliveryMacmillan Principles and GuidancePerfectly poised……????

background to prehabilitation in wales · jun 2011. jul 2011. aug 2011. sep 2011. oct 2011. days....

Documents